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Note to markers: This student has a disability which can affect the production 
of written language. Although the same standards are expected for all 
students, feedback on written language will be most beneficial if it is 
constructive and does not assume that shortcomings reflect a lack of effort. 
Deaf and dyslexic students may, as a result of their disability, struggle to produce written language 
which is grammatically correct and free of spelling errors. If this piece of work was produced on a 
computer with a spell-check facility, it is unlikely to reflect the range of difficulties which this student 
experiences. However, some difficulties may still be apparent and it should not be assumed that s/he 
has not checked his/her work. 
Obvious errors may include: 
 Spelling errors, including bizarre or inconsistent spellings; incorrect use of homophones (‗hear‘ for 
‗here‘, ‗there‘ for ‗their‘); and omission or transposition of letters, syllables and words. 
 Spell checker errors; while spell checking the work the student may have picked an incorrect word 
from the options given by the spell checker e.g. ―minuet‖ selected instead of ―minute‖  
 Sentences where it is clear that prepositions have been omitted or mistaken, e.g. ‗of‘ in place of 
‗on‘.  
 Incorrect or inconsistent use of tenses. 
 Long paragraphs that look like a single sentence but are composed of an undifferentiated string of 
simple sentences linked by conjunctions.  
 
Less obvious errors may include: 
 Sentences that change direction mid-stream: the student may have realised that the sentence 
requires the use of a word that they cannot spell and so rephrased the sentence to avoid a 
spelling error. 
 The use of a repeated sentence structure.  
 Apparent preference for simple words rather than more complex academic terms.  This may 
reflect the student's difficulties with rapid word retrieval or with spelling, and could create a false 
impression of an immature understanding of the topic.  
 Repetition of ideas, often using slightly different phrasing.  This may be because the student is not 
certain the point has been clearly made and has had a second (or third) attempt. 
 
Student Statement – You can use this space for things you would like the marker to know 
(e.g. what you found most difficult; what you worked hardest at; what you would most like 
feedback on): 
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Summary of Thesis 
Approximately a quarter of people with a long-term condition experience a comorbid 
mental illness.  This can result in poor clinical outcomes, quality of life and prognosis.  Cost-
effective psychological interventions which can improve outcomes are required.  Although 
empirical support for Acceptance and Commitment Therapy (ACT) has been growing in the 
last ten years, reviews in the context of group-based ACT are lacking.   
 
Paper 1 presents a systematic review of randomised-controlled trials of group-based ACT for 
adults with long-term conditions.  PsycINFO, MEDLINE and Web of Science databases were 
electronically searched and twelve studies met the inclusion criteria.  Study quality was 
assessed and study outcomes are summarised across a range of domains including 
depression, anxiety, quality of life and disability.  Overall, findings suggest that group-based 
ACT appears to be more effective than waiting list controls and as effective as other 
psychological interventions. 
 
Paper 2 presents a randomised pilot study of group-based ACT for stroke survivors.  To the 
authors’ knowledge, this is the first randomised study of group-based ACT with stroke 
survivors.  Fifty-three participants (60% male; mean age: 63 years) were randomly assigned 
to group-based ACT or to a treatment as usual (TAU) group.  The ACT intervention consisted 
of four weekly 2-hour group sessions.  Measures were completed at pre-treatment, post-
treatment and two month follow-up.  Results found that compared to participants in the 
TAU control, group-based ACT significantly reduced depression and increased self-rated 
health status and hopefulness in stroke survivors, with medium effect sizes.  Significantly 
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more participants reached clinically significant change of depression in the ACT intervention 
in comparison to the control group.   
 
Paper 3 is not intended for publication and consists of a critical appraisal of the research 
process.  Strengths and limitations of the research are discussed, as well as implications for 
future research, theory and clinical practice.  Personal-professional reflections are offered. 
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Abstract 
Purpose: Approximately a quarter of people with a long-term condition experience a 
comorbid mental illness which is likely to result in poorer clinical outcomes and prognosis. 
Psychological interventions which can improve outcomes are needed.  Empirical support for 
Acceptance and Commitment Therapy (ACT) has been growing in the last ten years.  Yet, 
reviews in the context of group-based ACT are lacking.   
Objectives: To review randomised controlled trials of group-based ACT for adults with long-
term conditions.   
Method: PsycINFO, MEDLINE and Web of Science databases were electronically searched 
and reference lists examined for relevant peer-reviewed articles.  All titles, abstracts and 
full-text papers were screened independently by two reviewers. Study quality was also rated 
independently by two reviewers and methodological rigour of reviewed studies discussed.  
Results: Twelve studies were included from a range of health conditions with a total of 756 
participants.  Study outcomes are summarised across a range of domains including 
depression, anxiety, quality of life and disability. Group-based ACT appears more effective 
than waiting list controls and as effective as other psychological interventions. 
Conclusion: Due to the increasing number of randomised controlled trials in this context, 
preliminary results are encouraging.  Studies with enhanced methodological rigour are 
required, particularly when considering the utility of ACT in comparison to other active 
treatment approaches. 
 
Keywords: Acceptance and commitment therapy, systematic review, long-term conditions, 
group-based, chronic illness. 
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Statement of Contribution 
 
What is already known on this subject? 
People with long-term conditions are more likely to experience anxiety and depression 
which can result in poor prognosis and clinical outcomes. Empirical studies evaluating the 
effectiveness of ACT interventions across numerous clinical settings have reported mixed 
findings.  There has been a recent surge of empirical studies examining the utility of group-
based ACT in physical health settings.  
 
What does this study add? 
 The first review of RCTs of group-based ACT for adults with long-term 
conditions. 
 Group-based ACT is more effective than TAU and as effective as other 
therapies. 
 Study quality is reviewed and recommendations are provided for improved 
rigour.  
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Introduction 
Long-Term Conditions 
A long-term condition (LTC) or chronic illness is defined as a condition that cannot currently 
be cured but can be controlled with the use of medication and/or other therapies 
(Department of Health, 2010).  Examples include arthritis, HIV, diabetes, chronic pain and 
cancer.  An estimated 40% of the adult European population have a LTC, while two thirds of 
older adults have at least two (Legido-Quigley, Panteli, Car, McKee, & Busse, 2013; World 
Health Organization, 2011).  Globally, low- and middle-income countries endure nearly 80% 
of the burden from LTC’s and their associated disability (World Health Organization, 2011).  
Living with an LTC often means living with uncertainty as many people worry about their 
capabilities to maintain their desired lifestyle and to cope with pain and illness symptoms 
(Heijmans et al., 2004).  Factors associated with psychological distress include disease 
severity, presence of pain and fatigue, disability, functional impairment, fear of activity and 
fear of death (Heijmans et al., 2004; Liddy, Blazkho, & Mill, 2014).  Many cancer survivors 
live with the fear of cancer re-occurrence (Ferrell, Grant, Funk, Otis-Green, & Garcia, 1998; 
Mullens, McCaul, Erickson, & Sandgren, 2004) and the continued burden of testing and 
monitoring (Deimling, Bowman, Sterns, Wagner, & Kahana, 2006).   
 
Approximately a quarter of people with an LTC experience comorbid mental illness which is 
two to three times more than the general population (Department of Health, 2009).  People 
with comorbid LTCs and psychological distress are less likely to adhere to medication and/or 
self-management plans (Bruce, Hancock, Arnett, & Lynch, 2010; Egede, Ellis, & Grubaugh, 
2009; Kalsekar et al., 2006; Tarrants, Oleen-Burkey, Castelli-Haley, & Lage, 2011), have 
increased contact with healthcare services (Levinson, Karger, & Haklai, 2008; McDonald, 
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2014), are at greater risk of health complications and/or disability (Lin et al., 2010; Tsai et 
al., 2012) and are more likely to experience reduced quality of life (QoL) (Gormsen, 
Rosenberg, Bach, & Jensen, 2010; Grandy, Chapman, & Fox, 2008; Rastenyte & Kranciukaite, 
2007). 
 
The UK’s Departments of Health recognises chronic pain conditions as LTC’s in their own 
right (Department of Health, 2012).  This definition warrants chronic pain conditions to be 
included within this LTCs review to ensure inclusivity.  Chronic pain conditions share 
common factors with other LTCs.  The Global Burden of Disease study found that four of the 
top twelve most disabling conditions globally were chronic pain conditions (low-back and 
neck pain, migraine, arthritis, other musculoskeletal conditions) and low-back pain is ranked 
number one worldwide, of 291 LTCs, for years lost to disability (Hoy et al., 2014).  Chronic 
pain conditions are associated with decreased health status and quality of life, and an 
increased risk of depression and loss of employment (Breivik, Eisenberg, & O’Brien, 2013; 
Breivik., Collett, Ventafridda, Cohen, & Gallacher, 2006). 
 
Acceptance and Commitment Therapy (ACT) 
ACT suggests that psychological distress is a facet of the human condition and does not 
primarily aim to reduce distress.  Instead ACT is based upon six principles to enhance 
‘psychological flexibility’ which enables people to better handle painful thoughts, feelings 
and sensations whilst living a meaningful life despite these experiences (Harris, 2013).  
Explaining ACT in depth is beyond the remit of this review; however a brief overview is 
outlined in Table 1.  
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ACT interventions for depression and mixed anxiety disorders were evaluated as superior 
when compared to waiting list (WL) controls and equivalent to other active psychological 
interventions (e.g. cognitive behavioural therapy; CBT) (Ruiz, 2012; Soo, Tate, & Lane-
Brown, 2011; Swain, Hancock, Hainsworth, & Bowman, 2013).  ACT has been applied across 
numerous physical health settings and a recent review concluded that ACT elicited 
promising outcomes regarding improved lifestyle, QoL, disease self-management, and 
reduced psychological distress (Graham, Gouick, Krahé, & Gillanders, 2016).  The use of ACT 
in chronic pain found significant effects for measures of pain intensity, pain-interference, 
disability, depression, anxiety and QoL.  ACT also had significantly higher effects on 
depression and anxiety than mindfulness based interventions (Veehof., Trompetter, 
Bohlmeijer, & Schreurs, 2016).  These findings support an earlier review (Veehof, Oskam, 
Schreurs, & Bohlmeijer, 2011).  A review of 60 RCTs concluded ACT is ‘probably efficacious’ 
for a number of populations and better quality studies would increase the likelihood that 
ACT will be reviewed as efficacious (Ost., 2014).   
 
Group-Based Interventions: Why Relevant? 
The rising prevalence of LTC’s is the main challenge facing governments and health-care 
services worldwide (World Health Organization, 2011).  Currently €700 billion are spent in 
the European Union annually on LTC’s, accounting for 70-80% of health expenditure 
(Kuipers Cavaco & Quoidbach, 2014).  Therefore, psychological interventions which can 
reduce healthcare consumption and improve outcomes are vital to reduce the economic 
burden (Department of Health, 2012; National Collaborating Centre for Mental Health, 
2010).  Identification of efficient, innovative and cost-effective interventions and delivery 
formats, e.g.  group-based interventions, are essential to manage LTC’s, their consequences 
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and increase the accessibility of psychological therapies (Kuipers Cavaco & Quoidbach, 2014; 
National Collaborating Centre for Mental Health, 2010).  
 
People with LTCs have reported that group-based intervention allowed them to meet 
people with similar experiences and undergoing similar medical procedures (Stafford et al., 
2013; Wylde, Marques, Artz, Blom, & Gooberman-Hill, 2014).  This can stimulate a shared 
group identity, peer learning and acceptance of chronic illness (Chambers, Foley, Galt, 
Ferguson, & Clutton, 2012).  Bringing people with LTCs together can decrease isolation, 
enhance emotional support, buffer against stress, and provide opportunities to gain 
knowledge (Nicholas, 2016).  Therefore, group-based psychological interventions could be 
the prudent choice, not only for the aforementioned benefits for patients, but also for the 
healthcare provider due to being more cost- and time-effective compared to individual 
interventions (Nicholas, 2016). 
  
Aims  
This review aimed to summarise RCTs of group-based ACT for adults with LTCs.  Despite two 
recent reviews evaluating the use of ACT within health contexts (Graham et al., 2016; 
Veehof. et al., 2016); these papers amalgamated studies using both individual and group 
interventions. These reviews also separated chronic pain and other LTCs samples whereas 
this present review reports inclusively on all LTC samples that met the inclusion criteria.  
Graham and colleagues (2016) reviewed child, adult and indirect samples (e.g. parents) and 
did not limit studies to RCTs.  Given the recent surge of group-based ACT RCTs in health 
contexts and the increasing pressure in healthcare settings to provide cost-effective and 
evidence-based treatments (Department of Health, 2012; Kuipers Cavaco & Quoidbach, 
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2014; World Health Organization, 2011), this is a timely review.  To the author’s knowledge, 
this is the first systematic review considering this specific use of group-based ACT. 
 
Method 
Search Strategy  
PsycINFO, MEDLINE and Web of Science databases were searched for published articles 
until the 31st January 2017.  No date restrictions or filters were placed on the search.  Search 
terms were: ‘acceptance and commitment therapy’ (searched as a subject heading and as a 
keyword only) or ‘acceptance and commitment’ in combination with ‘group*’ or 
‘workshop*’ or ‘training’ or ‘course*’ or ‘program*’.  As LTCs are categorised under a vast 
amount of diagnoses, a broad search strategy was completed. 
 
Eligibility 
RCTs were included if they evaluated group-based ACT (delivered face-to-face) and used all 
principles of the ACT model with a sample of adults with an LTC.  Articles were included if 
they were: quantitative, written in English and published in a peer-reviewed journal.  
Articles were excluded if the sample was indirect (e.g. staff groups, parents), or if they 
reported a secondary analysis on already published data. 
 
Study Selection and Data Extraction 
All titles, abstracts and full-text papers were screened independently by two reviewers.  
Disagreements were resolved through discussion and a consensus was identified.  A data 
extraction sheet was developed (Table 2) and one reviewer extracted the data from articles 
which met the inclusion criteria.  The second author checked the extracted data to ensure 
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accuracy.  Four authors were contacted for further information, however no responses were 
received. 
 
Quality Assessment 
Study quality was assessed using the Psychotherapy Outcome Study Methodology Rating 
Form (POMRF, Appendix 2) which has good internal consistency (Cronbach’s α = .86) and 
good interrater-reliability (intra-class correlation = .92) (Ost, 2008).  The POMRF consists of 
22 items and is designed to evaluate the methodological quality of psychotherapy-based 
studies.  Each item is rated on a 3-point scale from 0 to 2, where 0 = poor, 1 = fair and 2 = 
good.  Higher total scores suggest greater methodological quality.  Items two and four, 
which are related to reliability and severity of psychiatric diagnoses, were removed in line 
with an article also reviewing physical health orientated studies (Graham et al., 2016).  The 
maximum possible score was 40.   Two reviewers independently assessed the articles which 
met the inclusion criteria against the POMRF and when inconsistencies occurred, the articles 
were reassessed by both reviewers and disagreements were discussed until a consensus 
was reached.  Methodological quality rating totals are reported in Table 2 and individual 
item scores for each study can be seen in Appendix 3.   
 
Results 
The initial search produced 711 papers, after duplications were removed.  An additional 
paper was identified from full-text reference list searches.  Of these 712 articles, all titles 
and abstracts were screened, 678 articles did not meet the inclusion criteria.  Full texts were 
retrieved for the remaining thirty-four studies.  Of these, twelve papers met the inclusion 
criteria.  See Figure 1 for an overview of the study selection process. 
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Sample Characteristics 
Within the twelve studies, seven LTCs were represented: chronic pain (N=3), type-2 diabetes 
mellitus (T2DM; N=2), epilepsy (N=2), fibromyalgia (N=2), headache (N=1), breast cancer 
(N=1) and multiple sclerosis (MS; N=1).  Studies totalled 756 participants with sample sizes 
ranging from 18 to 156 (mean=63).  The majority of the participants were female (71.43%) 
and the average age was 46 years.  Study origins were Sweden (N=3), Iran (N=3), USA (N=2), 
Spain (N=1), India (N=1), South Africa (N=1) and UK (N=1).  Of the nine papers reporting the 
attrition rates of completing participants, the mean average was 17.81%. 
 
ACT Intervention 
One study implemented a one-off seven hour workshop (Gregg, Callaghan, Hayes, & Glenn-
Lawson, 2007) whereas the other ACT interventions consisted of several sessions lasting 1.5 
- 4 hours per session.  In these remaining eleven studies, the average number of sessions 
offered was eight, totalling an average of 15 hours.  The number of people per group ranged 
from six to twenty-four.  Four studies included LTC-specific psycho-education alongside the 
ACT material (Gregg et al., 2007; Lundgren, Dahl, Melin, & Kies, 2006; Lundgren, Dahl, Yardi, 
& Melin, 2008; Shayeghian, Hassanabadi, Aguilar-Vafaie, Amiri, & Besharat, 2016).  
However, only four studies were deemed to have a ‘good’ explanation of the intervention 
(Lundgren et al., 2006; Lundgren et al., 2008; Mo'tamedi, Rezaiemaram, & Tavallaie, 2012; 
Wicksell et al., 2013) therefore it is unknown if the other studies included additional 
information.    
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Control Conditions 
Eleven studies had one comparison group, except Luciano et al., (2014) who had two 
(recommended pharmacological treatment: RPT and WL).  Of those with one comparison 
group, four studies applied a TAU/WL control.  One study used supportive therapy as a 
control to provide equality of therapy hours (Lundgren et al., 2006).  Six studies used active 
treatment comparisons (education, applied relaxation, relaxation training, yoga, or CBT).  Six 
papers had treatment conditions which provided equality of therapy hours to both groups. 
 
Study Quality  
Nine studies obtained more than half of the available points on offer by the POMRF.  The 
mean score was 21.83 (SD: 6.07) and the range of scores were 9 – 33.  The highest rated 
paper was Kemani et al., (2015) while the lowest was Mohabbat-Bahar, Maleki-Rizi, Akbari, 
& Moradi-Joo (2015).  Eleven papers were rated as ‘fair’ for representativeness of the 
participant sample as they excluded participants with major disorders.  Ten studies were 
deemed to use ‘good’ outcome measures with good psychometric properties.  As well as pre 
and post measures, two studies conducted six and twelve month follow-up analysis 
(Lundgren et al., 2006; Lundgren et al., 2008), eight studies conducted a mixture of three 
and/or six month follow-up analysis, whereas two studies conducted only pre and post 
analysis (Mo'tamedi et al., 2012; Mohabbat-Bahar et al., 2015).  Three studies (Gregg et al., 
2007; Mohabbat-Bahar et al., 2015; Shayeghian et al., 2016) did not described the 
facilitators as practising therapists and/or clinically experienced.  Two studies (Kemani et al., 
2015; Wicksell et al., 2013) had three or more therapists delivering interventions and in the 
remaining ten studies, five had two therapists and five had only one.  Despite all the studies 
being an RCT, only five papers were rated as having a ‘good’ assignment to treatment 
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strategy (Kemani et al., 2015; Luciano et al., 2014; Lundgren et al., 2008; Wetherell et al., 
2011; Wicksell et al., 2013).  In terms of treatment fidelity, the POMRF highlighted that 
treatment adherence (item 16) and therapist competence (item 17) were rated identically.  
Three papers scored ‘good’ across both items (Kemani et al., 2015; Mo'tamedi et al., 2012; 
Wicksell et al., 2013), four were rated as ‘poor’ (Gregg et al., 2007; Mohabbat-Bahar et al., 
2015; Nordin & Rorsman, 2012; Shayeghian et al., 2016) and the remaining five papers were 
rated as ‘fair’.   
 
Some aspects of methodological quality were largely ignored, for example only four studies 
reported completing a power analysis prior to recruitment to inform sample size (Gregg et 
al., 2007; Kemani et al., 2015; Luciano et al., 2014; Shayeghian et al., 2016).  None of the 
studies detailed ‘good’ assessor training (ten studies did not specify at all) and only one 
paper reported the use of blind assessors (Wetherell et al., 2011).  No papers ensured that 
participants stopped all other treatments during the study although six studies asked 
participants to keep medication stable and/or discontinue other psychological therapies 
(Kemani et al., 2015; Lundgren et al., 2006; Lundgren et al., 2008; Mo'tamedi et al., 2012; 
Wetherell et al., 2011; Wicksell et al., 2013).  Three studies did not state attrition rates 
(Lundgren et al., 2006; Lundgren et al., 2008; Mohabbat-Bahar et al., 2015) and in an 
additional study, despite stating the attrition rate, an intent-to-treat analysis was not 
reported (Shayeghian et al., 2016).  Only four of the twelve papers reported Jacobson’s 
criteria for clinical significance (Kemani et al., 2015; Luciano et al., 2014; Lance M. 
McCracken, Sato, & Taylor, 2013; Wetherell et al., 2011).   
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Study Outcomes 
Depression. 
All four studies with TAU/WL controls found ACT demonstrated significant improvements on 
depressive symptoms at post-intervention  (Luciano et al., 2014; Lance M. McCracken et al., 
2013; Mohabbat-Bahar et al., 2015; Wicksell et al., 2013).  Effect sizes were reported as 
small (d = 0.44 - 0.46) (Lance M. McCracken et al., 2013; Wicksell et al., 2013) and large (d = 
1.01) (Luciano et al., 2014).  These significant group differences were maintained at three or 
six month follow-ups with medium to large effect sizes (d = 0.58 – 0.88) (Luciano et al., 
2014; Lance M. McCracken et al., 2013; Wicksell et al., 2013). 
 
 Four studies compared ACT to active treatment (Kemani et al., 2015; Luciano et al., 2014; 
Nordin & Rorsman, 2012; Wetherell et al., 2011) and findings were mixed.  Two higher 
quality studies showed that when ACT was compared against CBT and applied relaxation, all 
three active treatment approaches demonstrated significant reductions for depression at 
post-intervention and six month follow-ups but no significant differences occurred between 
treatment approaches (Kemani et al., 2015; Wetherell et al., 2011).  ACT was significantly 
more effective at reducing depression than RPT which was maintained at six month follow-
up with small effect sizes (d = 0.43; 0.37 respectively) (Luciano et al., 2014).  Relaxation 
training demonstrated significant improvements for depression, in comparison to ACT, at 
post-intervention which was not sustained at three month follow-up (Nordin & Rorsman, 
2012).   
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Anxiety. 
Four studies compared ACT to TAU/WL controls and found that ACT significantly reduced 
anxiety at post-intervention (Luciano et al., 2014; Mo'tamedi et al., 2012; Mohabbat-Bahar 
et al., 2015; Wicksell et al., 2013) with medium (d = 0.51 - 0. 77) (Luciano et al., 2014; 
Wicksell et al., 2013) and large (d = 2.54) effect sizes (Mo'tamedi et al., 2012).  Two of the 
four studies completed follow-up analysis and found these improvements were maintained 
at three months with medium (d = 0.55 & 0. 74) effect sizes (Wicksell et al., 2013) and at six 
months with a large (d = 0.85) effect size (Luciano et al., 2014). 
 
Four studies compared ACT to active treatment groups (Kemani et al., 2015; Luciano et al., 
2014; Nordin & Rorsman, 2012; Wetherell et al., 2011).  In a similar pattern for that of 
depression, when ACT was compared against active approaches of applied relaxation and 
CBT, all treatment approaches reported significantly reduced anxiety at post-intervention 
and follow-up but there were no significant differences between treatment groups (Kemani 
et al., 2015; Wetherell et al., 2011).  ACT was significantly more effective at reducing anxiety 
than RPT at post-treatment with a small effect size (d = 0.36) which was maintained at six 
month follow-up (d = 0.39) (Luciano et al., 2014).  However, in a lower quality study 
significant improvements from pre-treatment to three month follow-up were found in 
favour of relaxation training, when compared to ACT (Nordin & Rorsman, 2012). 
 
Quality of life. 
Seven studies assessed for changes in QoL (Kemani et al., 2015; Luciano et al., 2014; 
Lundgren et al., 2006; Lundgren et al., 2008; Lance M. McCracken et al., 2013; Wetherell et 
al., 2011; Wicksell et al., 2013).  A higher quality study found that both ACT and applied 
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relaxation improved QoL in a chronic pain sample (d = 0.79) (Kemani et al., 2015).  Other 
chronic pain studies found participant’s QoL did not significantly change following ACT, CBT 
or TAU at post-intervention or follow-up analysis (Lance M. McCracken et al., 2013; 
Wetherell et al., 2011).  ACT demonstrated significant improvements in mental health QoL 
when compared to WL controls with a large effect size at post-intervention (d = 0.84) and 
three month follow-up (d = 1.06) (Wicksell et al., 2013).  However, no significant changes in 
either group were found for physical health QoL (Wicksell et al., 2013).  ACT was 
significantly more effective at increasing QoL with fibromyalgia participants than RPT and 
WL controls at post-treatment and six month follow-up with medium to large effect sizes (d 
= 0.66 – 1.06) (Luciano et al., 2014). 
 
In a drug-refractory epilepsy sample, the Satisfaction With Life Scale (SWLS) outcome 
measure (Diener, Emmons, Larsen, & Griffin, 1985) changed  significantly, in favour of ACT 
when compared with supportive therapy across all time points with large effect sizes, 
whereas the WHOQOL-BREF (Amir et al., 2003) showed significant group differences only at 
one year follow-up, again in favour of ACT (d = 1.78) (Lundgren et al., 2006).  Interestingly, in 
Lundgren et al., (2008) ACT showed significantly improved QoL when compared to yoga on 
the WHOQOL-BREF however yoga showed improved QoL when compared to the ACT on the 
SWLS. 
 
Acceptance.  
Seven studies assessed changes in psychological and/or pain acceptance (Gregg et al., 2007; 
Kemani et al., 2015; Luciano et al., 2014; Lance M. McCracken et al., 2013; Nordin & 
Rorsman, 2012; Shayeghian et al., 2016; Wetherell et al., 2011).  When ACT was compared 
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to CBT, relaxation training or applied relaxation, all groups showed significant and similar 
improvement in pain acceptance (Kemani et al., 2015; Nordin & Rorsman, 2012; Wetherell 
et al., 2011).  However, in a higher quality study Kemani and colleagues (2015) found the 
ACT group had increased acceptance to a greater extent than the applied relaxation group 
(d = 0.90).  In comparison to RPT and WL groups, ACT was significantly more effective at 
improving pain acceptance at post-treatment and six month follow-up, with large effect 
sizes (d = 1.01 – 1.21) (Luciano et al., 2014).  In type-2 diabetes mellitus samples, 
significantly higher psychological acceptance was reported in the ACT group in comparison 
to education alone (Gregg et al., 2007; Shayeghian et al., 2016) with a large effect size 
(partial Ƞ2 = .12) (Gregg et al., 2007).  In contrast, McCracken and colleagues (2013) 
reported there were no significant group differences between ACT and TAU in psychological 
or pain acceptance at post-treatment, however at three month follow-up pain acceptance 
did become significant in favour of ACT, with a medium effect size (d = 0.64).  
 
Disability. 
Six studies assessed disability (Kemani et al., 2015; Luciano et al., 2014; Lance M. McCracken 
et al., 2013; Mo'tamedi et al., 2012; Wetherell et al., 2011; Wicksell et al., 2013).  ACT 
showed significant improvements in comparison to RPT and WL, at post-intervention and 
follow-up with small to large effect sizes (d = 0.41 – 2.35) (Luciano et al., 2014; Wicksell et 
al., 2013).  ACT also significantly reduced disability at post-intervention with  medium to 
large effect sizes (d = 0.75 - 0.93), in comparison to TAU and WL controls with chronic 
headache and fibromyalgia samples (Mo'tamedi et al., 2012; Wicksell et al., 2013), which 
was maintained at six month follow-up (d = 0.73) (Wicksell et al., 2013).  Both ACT and CBT 
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significantly improved pain interference from pre- to post-intervention, which was 
maintained at six month follow-up (Wetherell et al., 2011). 
 
In two of the studies with chronic pain populations outcomes fluctuated across time points. 
McCracken and colleagues (2013) found no significant differences for disability at post-
intervention yet at three month follow-up the ACT group showed significant improvements 
in comparison to the TAU group, with a medium effect size (d = 0.59).  Whereas, in Kemani 
et al., (2015) ACT significantly decreased pain disability in comparison to applied relaxation 
from pre- to post-analysis, however this was then mirrored by the applied relaxation group 
at follow-up. 
 
LTC-specific outcome. 
Significant findings with medium to large effect sizes (Ƞ2 = .08 - .25) were found at follow-up 
for diabetic control status (HbA1c < 7.0%) and diabetic self-management (Ƞ
2 = .07 - .22) in 
the ACT group when compared to education (Gregg et al., 2007; Shayeghian et al., 2016).  
Mediation analysis suggested that self-management and psychological acceptance mediated 
the impact of treatment on changes in HbA1c (Gregg et al., 2007), whereas in the lower 
quality study effective coping style were shown to moderate the relationship between ACT 
and diabetic self-management (Shayeghian et al., 2016). 
 
ACT, when compared to a supportive therapy, significantly reduced epileptic seizure 
frequency and index at post, six month and one year follow-up with large effect sizes (d = 
0.89 and d = 1.25 respectively) (Lundgren et al., 2006).  The participants in the ACT group 
had, on average, less than one seizure per month following the intervention yet the control 
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had no significant changes from pre-treatment.  ACT and yoga both significantly reduced 
seizure index, however the ACT group’s seizure index had reduced significantly more than 
the yoga group (Lundgren et al., 2008). 
 
There were no significant differences in pain severity or intensity in groups of ACT, applied 
relaxation, CBT or WL controls at post or follow-up analysis in chronic pain and fibromyalgia 
samples (Kemani et al., 2015; Lance M. McCracken et al., 2013; Wetherell et al., 2011; 
Wicksell et al., 2013).  However, ACT was significantly more effective at reducing subjective 
pain experience in fibromyalgia participants than RPT and WL groups at post-treatment and 
six month follow-up with small to large effect sizes (d = 0.47 – 0.93) (Luciano et al., 2014).  In 
a breast cancer sample, ACT produced a significant reduction in affective dimensions of pain 
(MPQ-SF) with large effect size (d=1.35) when compared to TAU. However no significant 
findings were found on the sensory dimension of pain (Mohabbat-Bahar et al., 2015).   
 
Discussion 
The aim of this review was to summarise RCTs of group-based ACT for adults with LTCs.  
Overall, twelve RCTs met the inclusion criteria for review and the findings from the higher 
quality papers suggest that group-based ACT significantly reduced anxiety and depression 
when compared to TAU/WL controls, and is equally as effective as other psychological 
treatments, such as CBT and applied relaxation.  Group-based ACT was found to significantly 
improve (psychological or pain) acceptance in comparison to TAU, RPT, WL and education 
however ACT, CBT, applied relaxation and relaxation training showed no significant group 
differences.  Similarly, ACT was superior at producing significant reductions in disability than 
WL, RPT and TAU conditions, whilst ACT, CBT and applied relaxation were generally equally 
29 
 
effective.  ACT was effective at reducing epileptic seizure index and increasing diabetic 
control status and self-management.  However, findings for pain severity and intensity were 
mixed.  Mixed conclusions were also drawn regarding the impact of ACT on QoL with limited 
consensus across studies.  Overall, group-based ACT interventions appear to be more 
effective than TAU/WL controls and as effective as other psychological therapies at reducing 
depression, anxiety and disability, and increasing acceptance and some LTC-specific 
outcomes in participants with LTCs.  However, conclusions regarding the effectiveness of 
group-based ACT at reducing pain experiences and increasing QoL outcomes remain 
unclear.  
 
A review which shares five papers with the current review also found limited evidence for 
the impact of ACT on pain intensity and the authors concluded that since pain control and 
reduction are not primary aims of ACT, it is unlikely that larger effects on participants’ pain 
experiences would be achieved (Veehof. et al., 2016).  Graham and colleagues (2016) (which 
shares four papers) made similar conclusions to this current review for outcomes of QoL but 
suggested that it was unclear whether ACT was superior to TAU and other psychological 
interventions for anxiety and depression, or whether the improvements observed were due 
to factors such as a regression to the mean, placebo or other therapeutic factors.  The 
interventions in their review had a low number of sessions offered, with 58% of the ACT 
interventions consisting of five sessions or fewer (Graham et al., 2016).  This is in contrast to 
the current review whereby only 25% of studies offered five sessions or fewer.  This is an 
interesting difference as the dose-effect relationship suggests that those receiving more 
sessions have better outcomes (Kopta, 2003).  In addition, group-based interventions may 
attract particular types of participants that are willing to engage in this format, as opposed 
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to individual therapy or medication, for example.  This may lead to a self-selected sample, 
with a preference for this format and may skew research outcomes (Wylde et al., 2014).  
These non-specific therapeutic factors are important considerations when appraising the 
effectiveness of interventions, however Hayes and colleagues outlined the evidence-base 
for the individual components of the ACT model (as outlined in Table 1) highlighting the 
efficacy of ACT in impacting relevant behaviours and processes of change which go beyond 
non-specific factors (Hayes, Levin, Plumb-Vilardaga, Villatte, & Pistorello, 2013). 
 
Considering that the rising prevalence of LTC’s is the main challenge facing governments and 
health-care services worldwide (World Health Organization, 2011), and comorbid LTCs and 
psychological distress result in poorer clinical outcomes and prognosis (Naylor et al., 2012), 
this review has found promising results for the utility of group-based ACT in this clinical 
sample.  The vast mix of study origins included in this review is particularly interesting as 
five of the twelve reviewed studies derived from low- or middle-income countries where the 
World Health Organisation found that nearly 80% of the burden from LTC’s occurs (World 
Health Organization, 2011).  All five of these studies showed some significant findings in 
favour of ACT, in a similar pattern to the remaining seven studies, suggesting that ACT has 
some efficacy across cultures and languages. This warrants further investigation. 
 
Strengths and Limitations 
To the authors’ knowledge, this is the first systematic review of group-based ACT for adults 
with LTCs.  Therefore, unlike previous ACT reviews, this paper has provided a focused 
framework to enhance the understanding of the effectiveness of ACT when specifically 
delivered in group formats.  The literature search was conducted in line with the Preferred 
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Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to ensure 
the search was systematic and transparent (Moher, Liberati, Tetzlaff, Altman, & The, 2009).  
Furthermore, this review has only included RCTs in an attempt to present the most 
efficacious research available. 
 
Since this review covered seven different LTCs it is difficult to draw firm conclusions about 
the effectiveness of group-based ACT for specific conditions or more generally across 
chronic health.  Although the studies measured largely similar components (i.e. depression, 
anxiety, etc.) many of the studies used different outcome measures meaning a meta-
analysis was not possible.  In addition, only one study (Kemani et al., 2015) assessed the 
cost-effectiveness of the ACT intervention.  ACT is still seen as a relatively new therapy and 
nine of the reviewed twelve studies were published in the last five years.  As interest in this 
therapy increases, particularly across different LTCs, a meta-analysis would be beneficial. In 
particular, focus is warranted on ACT in comparison to active interventions, as currently 
group-based ACT is generally only superior to TAU/WL controls and therefore it is difficult to 
determine any active agents of change.   
 
The POMRF quality measure highlighted concerns regarding model adherence as low quality 
ratings were found for item 13 (manualised, replicable specific treatment programs), item 
16 (checks for treatment adherence) and item 17 (checks for therapist competence).  
Therefore, it was difficult to confirm if the ACT interventions were comparable and offered 
participant’s similar information.  However, the POMRF is an extensive tool, and to score 
highly, authors must include a high level of detail.  Due to restrictive publication word 
counts, a study may have the appearance of poor methodological rigour however this does 
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not always mean high quality was not implemented (Swain, Hancock, Hainsworth, et al., 
2013).  Little is known about the association between POMRF scores and study outcomes.   
 
Recommendations for Improving Study Quality 
Useful recommendations to improve methodological rigour were made by Graham and 
colleagues (2016).  The current review highlighted further quality shortfalls and thus 
recommendations are: 
 Describe the prevalence of comorbid disorders in the sample description. 
 Compare ACT interventions to other active treatment and evaluate cost-
effectiveness 
 Complete a power analysis prior to recruitment and explicitly state that the sample 
size was decided accordingly. 
 Describe proportions of attrition, preform a drop-out analysis and present the results 
using intent-to-treat analysis. 
 
Conclusion 
This review highlighted promising findings for the use of group-based ACT across LTCs 
however high quality RCTs are required which compare group-based ACT against other 
active psychological therapies across a range of LTCs.  It is hoped that this review will 
highlight the potential of group-based ACT for providing effective, timely and accessible 
psychological input for people living with LTCs and will encourage further research and 
clinical attention to this topic. 
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Tables and Figures 
Table 1: An Overview of the Six Principles of ACT (Harris, 2013) 
ACT Principle Overview 
Experiential acceptance An active embrace of unpleasant feelings and sensations (e.g. 
feelings of pain or anxiety) without attempts to change or 
suppress them. 
Contact with the present 
moment 
Instead of worrying about the past and future, contact with the 
present moment is being connected to what you are doing and 
experiencing in any given moment. 
Cognitive defusion Defusion is the distance between the person and their 
unpleasant and self-critical thoughts which become products of 
perception and consequently less believable, frightening and 
powerful. 
Self-as-context A viewpoint from which one can observe their thoughts and 
feelings, without judgement, in an act of pure awareness. 
Values Direction and connection with what is important to individuals, 
providing significance and meaning to life.   
Committed action Taking effective and committed steps towards goals in line with 
a person’s values.   
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Figure 1: PRISMA Flow Diagram of Systematic Search. 
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Table 2: Study Characteristics 
Study 
POMRF 
quality 
score 
Physical 
health 
condition 
Country 
Sample 
size 
(total) 
Group 
sizes 
Mean 
age (% 
female) 
Control 
condition 
ACT 
Sessions 
(total hrs) 
Analysis 
time 
points 
Attrition 
% (ITT 
reported?) 
Outcome measures 
Gregg et al, 
(2007) 
 22 
Type-2 
Diabetes 
Mellitus 
USA 
ACT: 43 
E: 38 
(81) 
10-24 
50.9 
(46.9) 
Education (E) 
7hrs 
one 7hr 
workshop 
(7hrs) 
pre & 3 
month 
follow-up 
19 (Y) 
Glucose level (HbA1C), 
understanding of diabetes (DCP), 
self-management (self-report 
adherence measure),  psychological 
acceptance (AADQ) 
Kemani et 
al, (2015) 
33 Chronic pain Sweden 
ACT: 30 
AR: 30 
(60) 
6 
40.3 
(73.3) 
Applied 
relaxation 
18hrs (AR) 
12 
sessions 
1.5hrs 
(18hrs) 
pre, mid, 
post, 3 & 6 
month 
follow-up 
38 (Y) 
Pain disability (PDI),  Pain (scale 0-
6), QoL (SF-12), Anxiety & 
depression (HADS), Pain acceptance 
(CPAQ), Economic costs (TicP) 
Luciano et 
al, (2014) 
24 Fibromyalgia Spain 
ACT:51, 
RPT: 52, 
WL: 53 
(156) 
10-15 
48.31 
(96.2) 
Medication 
(RPT) & 
waiting list 
(WL) 
8 sessions, 
2.5hrs (20) 
pre, post, 
3 & 6 
month 
follow-up 
13 (Y) 
Fibromyalgia impact (FIQ), pain 
catastrophizing (PCS), anxiety & 
depression (HADS), pain acceptance 
(CPAQ), pain experience (PVAS), 
QoL (ED-5Q visual analog scale) 
Lundgren et 
al, (2006) 
22 
Drug-
refractory 
epilepsy 
South 
Africa  
ACT: 14, 
ST 13 
(27) 
13-14 
40.68 
(51.85) 
Supportive 
therapy 
12hrs (ST) 
2 sessions, 
3hrs + 4 
1:1 
sessions, 
1.5hrs (12) 
pre, post, 
6 & 12 
month 
follow-up 
Unknown 
(N) 
Seizure frequency, seizure index, 
QoL (WHOQOL-BREF), life 
satisfaction (SWLS) 
Lundgren et 
al, (2008) 
23 
Drug-
refractory 
epilepsy 
India 
ACT: 10, 
Yoga: 8 
(18) 
8-10 
23.85 
(33.33) 
Yoga 12hrs 
2 sessions, 
3hrs + 4 
1:1 
sessions, 
1.5hrs (12) 
pre, post, 
6 & 12 
month 
follow-up 
Unknown 
(N) 
Seizure frequency, seizure index, 
QoL (WHOQOL-BREF), life 
satisfaction (SWLS) 
McCracken 
et al, (2013) 
21 Chronic Pain UK 
ACT: 37, 
TAU: 36 
(73) 
12-13 
58 
(68.5) 
Treatment as 
usual (TAU) 
4 sessions, 
4hrs (16) 
pre, post, 
3 month 
follow-up 
23.29 (Y) 
Disability (RMDQ), depression 
(PHQ9), QoL (SF-36), pain intensity 
(scale 0-10), impression of change 
(PGIC), pain acceptance (CPAQ), 
psychological acceptance (AAQ-II) 
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Mo'tamedi 
et al, (2012) 
22 
Chronic 
Headache 
Iran 
ACT: 15, 
TAU: 15 
(30) 
15 
36.03 
(100) 
Treatment as 
usual (TAU) 
8 sessions, 
1.5hrs (12) 
pre & post 13.33 (Y) 
Pain intensity (MPQ-SF), disability 
(MIDAS), anxiety (STAI-T)  
Mohabbat-
Bahar et al, 
(2015) 
9 
Breast 
Cancer 
Iran 
ACT: 15, 
TAU: 15 
(30) 
15 
47.53 
(100) 
Treatment as 
usual (TAU) 
8 sessions, 
1.5hrs (12) 
pre & post 
Unknown 
(N) 
Anxiety (BAI), depression (BDI-II) 
Nordin et al, 
(2012) 
19 
Multiple 
Sclerosis 
Sweden  
ACT: 11, 
RT: 10 
(21) 
10-11 
45.75 
(76.19) 
Relaxation 
Training (RT) 
5 sessions 
(unknown) 
pre, post & 
3 month 
follow-up 
4.76 (Y) 
Anxiety & depression (HADS; BDI), 
psychological acceptance (AAQ-II) 
Shayeghian 
et al, (2016) 
16 
Type 2 
Diabetes 
Mellitus 
Iran 
ACT: 53 
E: 53 
(106) 
/ 
55.44 
(60) 
Education (E) 
2hrs 
10 
sessions 
(unknown) 
pre & 3 
month 
follow-up 
6 (N) 
Glucose level (HbA1C), self-care 
(SDSCA), psychological acceptance 
(AADQ), coping (COPE) 
Wetherell et 
al, (2011) 
30 Chronic Pain USA 
ACT: 57 
CBT: 57 
(114) 
4-6 
54.9 
(50.9) 
Cognitive 
Behaviour 
Therapy 
(CBT) 12hrs 
8 sessions, 
1.5hrs (12) 
pre, post, 
& 6 month 
follow-up 
25.44 (Y) 
Pain interference (BPI), QoL (SF12), 
depression (BDI-II), disability (MPI), 
anxiety (PASS), pain acceptance 
(CPAQ-R), pain control (SOPA) 
Wicksell et 
al, (2013) 
21 Fibromyalgia Sweden 
ACT: 23 
WL:17 
(40) 
6 
45.1 
(100) 
Waiting List 
(WL) 
12 
sessions, 
1.5hrs (18) 
pre, post & 
3 month 
follow-up 
17.5 (Y) 
Disability (PDI), fibromyalgia impact 
(FIQ), QoL (SF-36), depression (BDI), 
anxiety (STAI-T), pain scale 0-10, 
psychological inflexibility (PIPS) 
RPT= recommended pharmacological treatment, ITT=intention-to-treat analysis, Y=yes, N=no, DCP=Diabetes Care Profile, AA[D]Q=Acceptance and Action [Diabetes] Questionnaire, PDI=Pain Disability 
Index, QoL=quality of life, SF-12/36=Short Form-12/36 Health Survey, HADS=Hospital Anxiety and Depression Scale, CPAQ=Chronic Pain Acceptance Questionnaire, Tic-P=Trimbos and Institute of 
Medical Technology Assessment Cost Questionnaire for Psychiatry, FIQ=Fibromyalgia Impact Questionnaire, PCS=Pain Catastrophizing, PVAS=Pain visual analog scale, EQ-5D=European quality of life 
scale- 5 dimensions, WHOQOL-BREF=World Health Organization Quality of Life instrument short version, SWLS=Satisfaction with Life Scale, RMDQ=Roland and Morris Disability Questionnaire, PHQ-
9=Patient Health Questionnaire-9; PGIC=Patient global impression of change, MPQ-SF=McGill Pain Questionnaire-Short Form, MIDAS=Migraine Disability Assessment Scale, STAI-T=State-Trait Anxiety 
Inventory-Trait, BAI=Beck Anxiety Inventory, BDI-II=Beck Depression Inventory, BPI=Brief Pain Inventory Short Form Interference subscale, MPI=West Haven-Yale Multidimensional Pain Inventory, 
PASS=20-item Pain Anxiety Symptoms Scale-Short Form, SOPA=Survey of Pain Attitudes, PIPS=Psychological Inflexibility in Pain Scale, SDSCA=Summary of diabetes self-care activities, COPE=The brief 
COPE questionnaire
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Paper 2 has been prepared for submission to the British Journal of Health Psychology in 
accordance with the guidelines for authors (Appendix 1).  Therefore, tables and figures are 
presented at the end of the paper. 
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Abstract 
Objectives: To date, the effectiveness of Acceptance and Commitment Therapy (ACT) for 
stroke survivors has not been established.  The aim of this pilot study was to evaluate the 
effectiveness of group-based ACT for stroke survivors in comparison to treatment as usual 
(TAU) controls. 
Design & Method: Fifty-three participants were randomly assigned either to group-based 
ACT (ACTivate Your Life after Stroke) or to a TAU control group (60% male; mean age: 63 
years).  The ACT intervention consisted of four weekly 2-hour group sessions.  Therapeutic 
effects were measured by examining changes in depression, anxiety, hope, health related 
quality of life, self-rated health status and mental wellbeing.  Measures were completed at 
pre-treatment, post-treatment and two month follow-up.  A mixed-design repeated 
measures multivariate ANOVA was conducted to analyse the findings. 
Results: Analysis based on intention-to-treat found that compared to participants in the TAU 
control, group-based ACT significantly reduced depression and increased self-rated health 
status and hopefulness in stroke survivors, with medium effect sizes.  Significantly more 
participants reached clinically significant change of depression in the ACT intervention in 
comparison to the control group.   
Discussion: The results correspond with previous studies on group-based ACT with other 
long-term conditions.  The findings from this current study suggest group-based ACT may 
have promising utility and could offer a suitable cost-effective low-intensity psychological 
intervention for stroke survivors.  However further research is required. 
 
Keywords: Acceptance and commitment therapy, group-based, stroke. 
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Statement of Contribution 
What is already known on this subject? 
There are approximately 33 million stroke survivors living worldwide.  Approximately a third 
experience post-stroke depression and a quarter are affected by anxiety.  This can reduce 
stroke survivors’ quality of life and increase mortality.  National guidelines recommend that 
all stroke survivors are offered psychological support, yet evidence of cost-effective 
therapies are lacking. 
 
What does this study add? 
 This is the first randomised pilot study of group-based ACT with stroke 
survivors. 
 ACT significantly reduced depression, increased health status and hope, with 
medium effect sizes. 
 Clinically and statistically significant change in depression; 54% of ACT group 
vs. 7% of controls. 
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Introduction 
The World Health Organisation (WHO) defines stroke as “rapidly developing clinical signs of 
focal (or global) disturbance of cerebral function, with symptoms lasting 24 hours or longer, 
or leading to death” (WHO Monica Project Principal Investigators, 1988).  Approximately 17 
million strokes occur every year resulting in 5.9 million deaths, and 33 million stroke 
survivors living worldwide (Feigin et al., 2014).  Stroke affects many physical functions and 
consequently, 40% of stroke survivors are discharged from hospital requiring support with 
activities of daily living (Royal College of Physicians, 2015).  Stroke is considered to be one of 
the most common causes of complex disability, affecting over half of all stroke survivors 
(Adamson, Beswick, & Ebrahim, 2004).  The worldwide burden of stroke-related disability, 
illness and premature death is set to double by 2030 (Feigin et al., 2014). 
 
Psychological disabilities are common (Stroke Association, 2013).  A third experience post-
stroke depression which can persist long-term (Ayerbe, Ayis, Wolfe, & Rudd, 2013; Hackett, 
Yapa, Parag, & Anderson, 2005);  Anxiety affects around 25%, with many stroke survivors 
reporting a fear of another stroke (Townend, Tinson, Kwan, & Sharpe, 2006).  Moderate and 
severe fatigue affects 57% of stroke survivors (Lerdal et al., 2011).  The Stroke Association 
(2016) found that 73% of stroke survivors lacked confidence, 56% felt people treated them 
differently and 55% felt unable to care for their families as before.   
 
It is vital that evidence-based psychological interventions are available as stroke-related 
comorbidities and life-style changes are associated with reduced quality of life (Bays, 2001; 
Godwin, Ostwald, Cron, & Wasserman, 2013; Sturm et al., 2004) and increased mortality 
(Ayerbe et al., 2013).  Psychological distress in stoke survivors is also associated with 
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increased healthcare utilisation (Appleby, Thompson, & Galea, 2012; Ghose, Williams, & 
Swindle, 2005; van Eeden et al., 2016) and reduced functional recovery (Gillen, Tennen, 
McKee, & Gernert-Dott, 2001).   
 
Current Evidence for Psychological Interventions  
There is a lack of clarity regarding effective psychological interventions for stroke survivors 
(Royal College of Physicians, 2016).  A randomised controlled trial (RCT) found limited 
evidence for the use of cognitive behavioural therapy (CBT) with stroke survivors and 
reported that cognitive strategies were challenging for participants to implement (Lincoln & 
Flannaghan, 2003).  Several systematic reviews have concluded inconsistent and 
disappointing results regarding the effectiveness of psychosocial therapies including 
problem solving, goal setting, psycho-education and social support (Hackett, Anderson, 
House, & Halteh, 2008; Hackett, Anderson, House, & Xia, 2008; Sugavanam, Mead, Bulley, 
Donaghy, & van Wijck, 2013).  The current guidance for brief psychological interventions in 
stroke services includes motivational interviewing (MI), problem-solving therapy, or 
behavioural therapy (Royal College of Physicians, 2016).  An RCT reported that MI, delivered 
1:1 over four sessions, showed significant effects on mood at three months after stroke in 
comparison to a TAU group, but no effects were found on function or expectation of 
recovery (Watkins et al., 2007).  The MI group demonstrated improved mood and reduced 
mortality at twelve months post-stroke (Watkins et al., 2011).  Behavioural therapy, when 
compared with TAU in an RCT found significant improvements in self-reported and 
observer-rated mood, and self-esteem, at three months in stroke survivors with aphasia and 
low mood (Thomas, Walker, Macniven, Haworth, & Lincoln, 2013).  Behavioural therapy 
consisted of twenty hour-long sessions, delivered over three months at the participants’ 
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home, yet cost analysis showed some savings in resource utilisation at six month follow-up, 
in comparison to a TAU group (Humphreys, Thomas, Phillips, & Lincoln, 2014).  Group-based 
problem solving therapy, delivered over eight sessions, significantly improved task-oriented 
coping but not disease-specific quality of life in stroke survivors at six month follow-up in 
comparison to a TAU control (Visser et al., 2015).  However these guidelines of psychological 
interventions for stroke survivors are based on only a few empirical studies and delivery 
formats were resource intensive (i.e. 1:1 or numerous group session).  Therefore there are 
limited suitable options for stroke survivors and research is needed to investigate 
alternatives approaches. 
 
Acceptance and Commitment Therapy (ACT)  
ACT suggests that psychological distress is a natural aspect of human experience and 
therefore its primary aim is not to rid a person of their distress.  Instead ACT aims to 
increase ‘psychological flexibility’ which allows people to lead a valued life despite 
experiencing painful thoughts, feelings or sensations (Harris, 2013).  ACT consists of six core 
principles (Harris, 2013):  
 Experiential acceptance: opening up to unpleasant feelings without attempts to 
suppress or change them 
 Contact with the present moment: being connected with the experience in any given 
moment rather than ruminating about the past or future 
 Cognitive defusion: reducing the power and believability of thoughts by developing 
distance between the person and their unpleasant or self-critical thoughts 
 Self-as-context: a viewpoint where a person observes their internal experiences 
without judgement 
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 Values: connecting with what is important to a person which provides meaning and 
significance to life 
 Committed action: committing to goals which are in line with a person’s values 
 
There is a growing body of research in support of ACT across a wide range of clinical samples 
(Graham et al., 2016; Ost., 2014; Ruiz, 2012; Swain, Hancock, Dixon, Koo, & Bowman, 2013; 
Veehof. et al., 2016).   Group-based ACT has been applied to several health conditions 
including cancer, multiple sclerosis, epilepsy, diabetes and chronic pain with promising 
findings in reducing depression, anxiety and disability and increasing acceptance and other 
condition-specific outcomes (Gregg et al., 2007; Kemani et al., 2015; Lundgren et al., 2006; 
Lundgren et al., 2008; Lance M. McCracken et al., 2013; Mohabbat-Bahar et al., 2015; 
Nordin & Rorsman, 2012; Wetherell et al., 2011).   A single case report outlined benefits for 
the use of ACT with an adult experiencing post-stroke anxiety (Graham, Gillanders, Stuart, & 
Gouick, 2014).  ACT does not require the ability to learn complex strategies nor rely on 
cognitive ability for high level reasoning therefore ACT is a promising intervention to 
consider for people with cognitive impairment (e.g. stroke survivors) and research suggests 
that ACT has utility in acquired brain injury (Kangas & McDonald, 2011; Soo et al., 2011).   
 
Stroke and Psychological Provision 
The National Clinical Guidelines for Stroke suggest services should offer brief psychological 
interventions to all stroke survivors with, or at risk of, depression or anxiety (Royal College 
of Physicians, 2016).  However, these stroke guidelines recognise many current 
commissioning arrangements do not include psychological provision (Royal College of 
Physicians, 2016).  In one survey, almost three-quarters of stroke survivors experiencing 
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emotional distress felt their psychological needs were not being met (McKevitt et al., 2011).  
The guidelines urge commissioners to include clinical psychology in stroke rehabilitation 
multi-disciplinary teams, as well as to plan for the long-term management of psychological 
distress (Royal College of Physicians, 2016).   The disability-adjusted life years (DALYs) lost 
post-stroke in low and middle-income countries, where resources are most stretched, was 
almost seven times higher than those lost in high-income countries (Feigin et al., 2014).  
Additionally, the UK’s Department of Health (2012) acknowledged that people living with 
long-term conditions is currently the biggest challenge facing the National Health Service 
(NHS).   Therefore, it is vital that research focuses on the effectiveness of innovative and 
cost-effective delivery formats, such as group-based interventions, to enhance the 
accessibility of psychological support (National Collaborating Centre for Mental Health, 
2010). 
 
Objectives of Current Study  
The aim was to assess the preliminary effectiveness of group-based ACT for stroke survivors 
(‘ACTivate Your Life after Stroke’) in comparison to a treatment as usual (TAU) control 
group.  To the authors’ knowledge, this is the first randomised pilot study of an ACT 
intervention with this clinical population.   
 
Research suggests that non-acceptance of stroke-related disability is associated with 
depression after controlling for age, gender, original stroke severity and current disability at 
one month and nine months follow-ups (Townend, Tinson, Kwan, & Sharpe, 2010).  The ACT 
intervention promotes acceptance of stroke-related disability therefore it was hypothesised 
that stroke survivors who attend the ACT intervention will have a reduction in depression 
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across pre-treatment, post-treatment and follow-up time points, in comparison to the 
control group, which would be evidenced by an ANOVA interaction between group and 
time.  It was also hypothesised that significant interactions would occur in the ACT group for 
anxiety, health-related quality of life, self-reported health status, hopefulness and mental 
wellbeing, across the three time points in comparison to the TAU control group.  
 
Methods 
Participants and Procedure 
Stroke survivors were invited into the study by clinical stroke teams across three NHS sites 
in south Wales and one in south west England if they: had at least one clinically diagnosed 
stroke, were discharged from hospital, were over 18 years old and did not have severe 
communication difficulties (e.g., aphasia) or cognitive impairments.  Stroke survivors were 
not eligible if they had: another acquired brain injury (e.g. traumatic brain injury, 
encephalitis, tumours), a diagnosed degenerative condition (e.g. dementia), or a severe 
mental illness (e.g. psychosis).  Potential participants were given an ‘ACTivate Your Life after 
Stroke’ course leaflet (Appendix 4), a participant information sheet (Appendix 5) and a 
consent form (Appendix 6). 
 
Internet software (www.randomizer.org) was used by the researcher to randomly generate 
a number sequence of 1’s (intervention) and 2’s (TAU control group who would then be 
invited to attend an ACT course when the study was completed) and a parallel group study 
design was utilised.  Potential participants were referred by the clinical team to a designated 
person within each site (not the researcher), who was responsible for enrolling participants 
and group allocation.  Once participants consented (in ignorance of the next assignment in 
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the sequence), their names were put into the spreadsheet in a consecutive manner and the 
associated number from the random number sequence indicated the group they were 
randomised to.  No restrictions to randomisation were used.  Letters were then sent to 
participants to let them know which group they had been allocated to and their course 
dates.  For obvious reasons, this study could not be blinded.  The study employed a 
longitudinal design using a questionnaire methodology.  All outcome measures were 
collected by the researcher at pre-intervention (immediately prior to the first session), post-
intervention (immediately following the final session) and at two month follow-up.  The 
control group responded at the same time points and were returned by post or over the 
telephone.   
 
Study Conditions 
ACT intervention. 
The ACT intervention, ‘ACTivate Your Life after Stroke’, consisted of two hour weekly group 
sessions, for four consecutive weeks.  On sessions one and four an extra half an hour was 
allocated for study questionnaire completion.  Due to the trans-diagnostic (applies to more 
than one condition) nature of ACT (Lang et al., 2012) carers were invited to the course but 
were not part of the study analysis.  The material was psychoeducational and delivered by 
Microsoft PowerPoint with several non-interactive activities throughout, such as guided 
mindfulness practices.  The intervention was developed from Professor Neil Frude’s 
‘ACTivate your life’ course (Cartwright & Hooper, in press), employed across NHS mental 
health services within south Wales, and was adapted for mild aphasia and included stroke 
specific examples.  Adaptations to the presentation to account for mild aphasia consisted of 
reducing the number of words on the screen; minimising busy backgrounds; and avoiding 
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contrasting colours on the presentation i.e. to avoid red font against a blue background.   
Also, some stroke specific thought examples were added to the presentation e.g. “what if I 
have another stroke” or “you’re not improving as fast as you were before”.   These 
modifications were consistent across all sites and were made in consultation with service 
users and professionals working in stroke rehabilitation settings.  The session-by-session 
outline is illustrated in Table 1.  A handout was provided for each session which included a 
session summary and suggested home activities. 
 
All courses were run in community venues, e.g. local library, and each of the four sites 
(three NHS in south Wales and one third sector organisation in south west England) had at 
least two facilitators consisting of clinical psychologists, assistant psychologists or stroke 
care co-ordinators.  All of the course facilitators received the same intensive two day 
training. 
 
TAU control group.  
Participants in the control group followed their usual treatments.  After the two month 
follow-up data was collected, the control group were offered the intervention which 
consisted of the exact same material, course facilitators and time period as the first group.  
 
Measures 
Socio-demographical information.  
The following information was collected: age, gender, date of first stroke and most recent 
stroke (if applicable), type and location of stroke (if known), employment status, living 
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arrangements and experience of mental health conditions since stroke and therapy 
received, if applicable (Appendix 7). 
   
Primary Measure 
Depression. 
Patient Health Questionnaire-9 (PHQ-9; Appendix 8) measure was used to screen for 
depression.  The PHQ-9 is widely used and has good validity (sensitivity of 88% and 
specificity of 88%), internal reliability (Cronbach's α of .89) and test-retest reliability 
(correlation = .84) in a primary care sample (Kroenke, Spitzer, & Williams, 2001) and 
performs well as a screening tool for post-stroke depression (Williams. et al., 2005). 
 
Secondary Measures 
Anxiety. 
The Generalized Anxiety Disorder-7 (GAD-7; (Appendix 9) measure was used to screen for 
anxiety (Spitzer, Kroenke, Williams, & Lowe, 2006).  It has good validity (sensitivity of 89% 
and specificity of 82%), internal reliability (Cronbach’s α of.92) and test-retest reliability 
(intraclass correlation; ICC = .83) in a primary care sample.  It is also moderately good at 
screening for a variety of other anxiety disorders (Kroenke, Spitzer, Williams, Monahan, & 
Lowe, 2007). 
 
Health related quality of life (HRQoL). 
The EQ-5D-5L (Herdman et al., 2011) (Appendix 10) has good internal reliability (ICC = .57) 
and test-retest reliability (ICC = .69) across health samples (Janssen, Birnie, Haagsma, & 
Bonsel, 2008) and has been validated in stroke samples (Dorman, Waddell, Slattery, Dennis, 
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& Sandercock, 1997; Golicki et al., 2015).  Scores in this current study were converted to 
normed value sets (Devlin, Shah, Feng, Mulhern, & van Hout, 2016). 
 
Self-reported health. 
Part two of the EQ-5D-5L (Herdman et al., 2011) (Appendix 10) was used to measure self-
reported health. This consists of a 20cm visual analogue scale which asks users to indicate 
from 0 to 100 ‘how good is your health today?’  Test–retest reliability was reported as ICC = 
0.51 across health samples (Janssen et al., 2008) and has been validated in stroke samples 
(Dorman et al., 1997; Golicki et al., 2015). 
 
Hope. 
The Adult Hope Scale (AHS; Appendix 11) (Snyder et al., 1991) was used to assess hope.  
Total scores from the eight active items range from zero to 48 and higher scores indicate 
greater hopefulness.  The questionnaire is internally consistent (Cronbach’s α ranging from 
.74 to .84); shows good test-retest reliability (Cronbach’s α ranging from .73 to .85) and 
good validity across student and clinical populations (Snyder, 2002; Snyder et al., 1991).  
 
Mental Wellbeing. 
Warwick and Edinburgh Mental Wellbeing Scale (WEMWBS; Appendix 12) has good validity, 
internal consistency (Cronbach’s α = .91) and test-retest reliability (ICC = .83) in general 
population and student samples (Tennant et al., 2007).  It comprises of 14 items and a 
higher score indicates greater mental wellbeing.  Mental wellbeing describes positive states 
of being, thinking, behaving and feeling.  
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Sample Size 
A similar randomised study  (Lance M. McCracken et al., 2013) using the PHQ-9 to 
investigate the impact of group-based ACT in a health setting found the ACT group, in 
comparison to a TAU group, were significantly less depressed at post-treatment (d = .46) 
and at three month follow-up (d = .58).  Based on these effect sizes, a power analysis was 
conducted using G* Power (Faul, Erdfelder, Lang, & Buchner, 2007).  In order for sufficient 
power (0.80) and using standard parameters of alpha = 0.05, a total sample size of between 
40 - 64 participants was required. 
 
Statistical Methods 
An intention-to-treat (ITT) approach was used with imputation of missing data by last value 
carried forward (Streiner & Geddes, 2001).  Effect sizes are reported as partial eta-squared 
(partial Ƞ2) and are categories against the suggested values of 01, .06, and .14 to indicate 
small, medium, or large effects (Richardson, 2011). 
  
 Primary outcome.  
A mixed-design repeated measure ANOVA was used to analyse the interaction between the 
two groups and depression outcome across the three time points.  The experimental 
hypothesis stated there would be an interaction between group and time for depression 
therefore the group*time interaction will be reported.  There is no basis to report main 
effects because randomisation should insure that the scores of the two groups are 
equivalent at baseline which would mitigate any group differences across all three time 
points.  To assess for group differences in clinically significant change, a Chi Square analysis 
was conducted.  To identify when significant differences occurred between the groups two 
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mixed-design repeated measures ANOVAs were conducted (pre-intervention to post-
intervention or pre-intervention to two month follow-up).  This was conducted because 
although there were no significant differences between the groups at baseline, there were 
differences in the means, in that the ACT group had a higher mean (see Table 2); therefore 
differences would not necessarily be expected in means at post-treatment or at follow-up.  
However, it would be expected that a greater change would occur pre-treatment to post-
treatment and pre-treatment to follow-up since the ACT group would change in a positive 
direction in comparison to the TAU group, hence interaction was tested for.  As an index of 
change, interaction is a better measure than differences in means. 
 
 Secondary outcomes. 
A mixed-design repeated measures multivariate ANOVAs was used to analyse the 
interaction between the groups and the five aforementioned secondary outcome variables 
across the three time points.  To assess where significant differences occurred between the 
groups two further mixed-design repeated measures multivariate ANOVAs were conducted 
(pre-intervention to post-intervention or pre-intervention to two month follow-up).   The 
experimental hypothesis stated there would be an interaction between group and time for 
anxiety, quality of life, self-reported health, hope and mental wellbeing  variables therefore 
the group*time interaction will be reported.  There is no basis to report main effects 
because randomisation should insure that the scores of the two groups are equivalent at 
baseline which would mitigate any group differences across all three time points.   
 
Debrief 
At the end of the study, participants were given a debrief form (Appendix 13). 
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Ethical Approval 
This study was given a favourable opinion by the London - City & East Research Ethics 
Committee (Appendix 14 – 19).  
 
Results 
Participant Flow  
Figure 1 illustrates the flow of participants through each arm of the study.  Recruitment 
occurred between February and April 2016, the four courses of ‘ACTivate Your Life after 
Stroke’ intervention ran throughout April, one at each site, and two month follow-up data 
was collected in June 2016.  Data on those initially invited to the study by the clinical teams 
could not be recorded as ethical approval allowed participant details to be collected only 
after consent.  53 participants were recruited in total and analysis was completed on all 
recruited participants in their original assigned groups, ACT N=26, control N=27.  All 26 
participants in the group-based ACT intervention attended at least three of the four 
sessions, of which 19 (73.1%) attended all four sessions.  The attrition rate was low: 25 
(96.2%) and 22 (84.7%) participants completed the post-treatment and the 2-month follow-
up assessments in the intervention arm and 23 (85.2%) and 25 (92.6%) in the control arm.  
As a result of the low rate of dropouts, the predictors of dropout were not subjected to 
further analysis.  Due to ethical reasons, the courses were open to stroke survivors and 
carers who did not wish to participate in the study.  Total group sizes varied from six to 
twenty-two attendees across the four groups.  Group sizes of stroke survivors who 
consented to participant in the research study varied from three to nine across the four 
groups which is detailed in Table 2. 
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Sample Characteristics 
The means and standard deviations of participant demographics and outcome measures at 
baseline are summarised in Table 3.  Independent sample t-tests were conducted with 
Bonferroni correction, to compare the group at pre-intervention.  Significant differences 
were found for gender whereby the ACT group had significantly more males.  Although 
qualitative data were collected regarding stroke details (e.g. location and type), the data 
were too heterogeneous to analyse or comment on.  There were no significant differences 
between the groups on the outcome measures at baseline, suggesting the groups were 
comparable on these measures as they entered into the study.   
 
Primary Outcome  
A mixed-design repeated measures ANOVA revealed a significant overall time*group 
interaction for depression, in favour of ACT over TAU, F (2, 102) = 3.875, p =.024 with a 
medium effect size (partial Ƞ2 = .071).  This interaction is shown in Figure 2 and means and 
standard deviations are illustrated in Table 4.  This group differences remained significant at 
pre-treatment to post-treatment analyses F (1, 51) = 4.103, p =.048 with a medium effect 
size (partial Ƞ2 = .074) and pre-treatment to two month follow-up analyses F (1, 51) = 5.901, 
p =.019 with a medium effect size (partial Ƞ2 = .104).   
 
Clinically significant change. 
The PHQ-9 defines clinically significant change as a score of ≤ 9 combined with improvement 
of 50% from the pre-treatment scores (Kroenke et al., 2001; McMillan, Gilbody, & Richards, 
2010).  At post-treatment a significant group difference occurred, χ(1) = 5.352, p = .021, 
whereby 38.5% (N=10) of the ACT group had reached a clinically significant change, in 
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comparison to 11.1% (N=3) in the control group.  This significant group difference continued 
at two month follow-up in favour of ACT, χ(1) = 13.554, p = .000.  The total number of 
participants in the ACT group to reach a clinically significant change from pre-treatment was 
53.8% (N=14) whereas in the control group it was 7.4% (N=2).  
 
Secondary Outcomes 
A mixed-design repeated measures MANOVA across the three phases revealed a significant 
overall multivariate main effect for time*group interaction, Wilks’ λ = .56, F (10, 42) = 3.26, 
p = .003, partial Ƞ2 = .437.  Power to detect the effect was .97.  Given the significance of the 
overall test, the univariate main effects were examined and significant findings were 
obtained in favour of ACT over TAU for self-reported health status F (1.75, 102) = 4.219, p = 
.022 and hopefulness F (1.65, 102) = 4.223, p =.017, all with medium effect sizes (partial Ƞ2 = 
.076 for both variables).  No significant effects were found for HRQoL, anxiety or mental 
wellbeing. These overall trends can be seen in Figure 2 and overall means and standard 
deviations are illustrated in Table 4. 
 
To assess the outcome measures between the groups and across time points, two mixed-
design repeated measures MANOVA's were conducted to evaluate the interaction from pre-
treatment to post-treatment, and then from pre-treatment to follow-up.  Pre-treatment to 
post-treatment analyses found a significant multivariate main effect for the time*group 
interaction, Wilks’ λ = .699, F (5, 47) = 4.054, p = .004, partial Ƞ2 = .301.  Power to detect the 
effect was .927.  Univariate main effects revealed significant findings in favour of ACT in 
comparison to TAU for hopefulness F (1, 51) = 10.49, p =.002, with a large effect size (partial 
Ƞ2 = .171).  Although mental wellbeing did not reveal an overall effect across the three time 
62 
 
points in the initial repeated MANOVA, pre to post-intervention significance was reached in 
favour of ACT in comparison to TAU, F (1, 51) = 4.162, p =.047 with a medium effect size 
(partial Ƞ2 = .075).  Self-reported health showed a strong trend in favour of ACT, but did not 
reach significance (p = .057).  Significant effects were not found for anxiety or HRQoL in this 
pre-post intervention analysis. 
 
Pre-treatment to follow-up treatment analyses found a significant multivariate main effect 
for time*group interaction, Wilks’ λ = .779, F (5, 47) = 2.666, p = .033, partial Ƞ2 = .221.  
Power to detect the effect was .763.  There were no significant univariate effects. 
 
Discussion 
The aim of this randomised study was to seek preliminary findings regarding the 
effectiveness of a group-based ACT intervention to assess if it appears to be a suitable 
psychological treatment for stroke survivors in comparison to a TAU control group.  This 
study found that the ACT intervention significantly reduced depression and increased 
hopefulness and self-reported health status in stroke survivors in comparison to the TAU 
control group, with medium effect sizes.  
 
The participants in the ACT group had a significant reduction of depressive symptoms from 
pre-treatment to post-treatment which was maintained during the two month follow-up 
period, with medium effect size, in comparison to the TAU control group.  As a result, nearly 
54% of participants in the ACT group had had a clinically and statistically significant change 
in depression scores at the two month follow-up in comparison to only 7% of the control 
group.  As well as the overall interaction, hope scores revealed significant differences 
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between groups, in favour of ACT, from pre-treatment to post-treatment but this significant 
difference was not maintained at follow-up.  As illustrated in Figure 2, the ACT group’s 
improvement in hopefulness was maintained from post-intervention to follow-up but group 
differences were no longer found due to the control group’s outcome scores becoming 
comparable at follow-up.  In addition, self-reported health status followed a similar pattern 
to that of hope.  Finally, the outcome variable for mental wellbeing did not produce an 
overall significant result across the three time points, however pre-intervention to post-
intervention analysis found significant group differences, in favour of ACT.  There were no 
significant group differences on measures of anxiety or HRQoL. 
 
The reduction of depressive symptoms and the increase in self-reported health status and 
hopefulness in the participants who attended the ACT group are particularly interesting in 
the context of the aims of ACT, which does not primarily aim to reduce distress or improve 
health.  Instead ACT aims to help people to live a valued life despite these unpleasant 
experiences (Harris, 2013).  In line with this ethos, the improved hopefulness in the ACT 
group makes theoretical sense as participants were taught skills to take committed action to 
move towards a more meaningful life.  Yet it is interesting that there were no significant 
differences in HRQoL.  This may suggest that actual changes did not occur to participants’ 
physical abilities in everyday tasks such as mobility, self-care and pain/discomfort, which 
would be an expected result of an ACT intervention.  Yet despite such difficulties remaining 
relatively static throughout the study, the participants in the ACT group perceived their own 
health status as significantly better than the control group following the intervention.   A 
cautious hypothesis of this outcome, in line with the ACT philosophy, is that the ACT 
intervention stimulated participants to experience a change of relationship with their health 
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difficulties as they learn to accept what they cannot change and focus on goals that are 
achievable and meaningful instead.  However, these processes of change need much further 
investigation to be understood more clearly. 
 
The significant reduction of depressive symptoms in the ACT group in comparison to the 
control group mirror findings of similar RCTs using group-based ACT with other physical 
health conditions, such as chronic pain, fibromyalgia and breast cancer patients (Luciano et 
al., 2014; Lance M. McCracken et al., 2013; Mohabbat-Bahar et al., 2015; Wicksell et al., 
2013).  When compared to TAU or waiting list controls, group-based ACT demonstrated 
significant improvements on depressive symptoms at post-intervention with small (d = 0.44 
- 0.46) (Lance M. McCracken et al., 2013; Wicksell et al., 2013) and large (d = 1.01) effect 
sizes (Luciano et al., 2014).  These significant improvements were maintained at three or six 
month follow-ups with medium to large effect sizes (d = 0.58 – 0.88) (Luciano et al., 2014; 
Lance M. McCracken et al., 2013; Wicksell et al., 2013).  However, it is important to note 
that when group-based ACT was compared to active treatments in chronic pain samples, 
such as CBT and applied relaxation, there were no significant differences between the 
interventions as all groups reported a reduction in depressive symptoms (Kemani et al., 
2015; Wetherell et al., 2011).  So the effectiveness of ACT in comparison to other 
treatments in stroke, as in other conditions, is an area requiring further research. 
 
Outcome measures for hope do not appear to be commonly used in studies to assess the 
effectiveness of ACT-based interventions.  One study was found which specifically assessed 
hope following a group-based ACT intervention in a health setting and it reported that the 
ACT intervention was effective in increasing hopefulness in patients with cancer (Ghasemi, 
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Dehghan, Farnia, Tatari, & Alikhani, 2016).  Snyder and colleagues (1991) defined hope as a 
motivational state based on pathway thinking (a person’s belief in their ability to produce 
and plan at least one effective path to their desired goals) and agency thinking (a person’s 
belief in their ability to initiate and sustain the actions necessary to reach their goals).  One 
aim of ACT is to support individuals to develop greater psychological flexibility through 
identifying their values, goal setting accordingly and choosing to take committed action to 
live a meaningful life (Harris, 2013).  The significant increase in participants’ hopefulness in 
the current study is relevant as higher levels of hope are associated with improved 
treatment adherence, ability to cope with illness and loss and enhanced psychological 
adjustment (Snyder, 2002; Van Servellen, Chang, Garcia, & Lombardi, 2002; Weis & 
Speridakos, 2011).  However, the relationship between ACT and hopefulness requires 
further investigation. 
 
Implications for Further Research and Service Delivery 
Although preliminary, these findings suggest that a full RCT of ACT for stroke would be 
viable and could provide confirmation of its efficacy.  In countries such as the UK, many 
stroke units report no access to psychology services (Royal College of Physicians, 2012); yet 
40% of stroke survivors felt abandoned after leaving hospital; 50% did not receive any 
information or support for anxiety or depression; and two-thirds said their emotional needs 
were not met as well as their physical needs following their stroke (Stroke Association, 
2013).  Healthcare cost for patients with long-term conditions and comorbid depression will 
typically be 45% greater than patients without comorbid depression (Naylor et al., 2012).  
Due to the non-interactive nature of group-based ACT it has potential to be a cost-effective 
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low intensity psychological intervention as, in principle, there is no limit to the number of 
people who can attend a course.     
 
Strengths and Limitations 
Some strengths of this study are that the group-based ‘ACTivate Your Life after Stoke’ 
intervention was cost-effective, can be delivered by non-specialists with limited training, 
and was associated with favourable outcomes in depression, hopefulness and self-reported 
health status, with a sizeable proportion of participants reaching clinically and statistically 
significant change for depression.  An additional strength was that this ACT intervention was 
specifically adapted by a team of service users and professionals from local stroke services 
to ensure the presentation accounted for mild aphasia and included stroke specific 
examples.  The intervention offered stroke survivors access to a community-based 
psychological intervention, regardless of when their stroke occurred which is in line with 
guidance which recommends that all stroke survivors should be offered psychological 
support (Royal College of Physicians, 2016).  To the authors’ knowledge, this was the first 
study to explore the outcome of tailored group-based ACT for stroke survivors. 
 
A limitation of this study is that the ACT intervention did not appear to make a differential 
impact on participants’ anxiety levels beyond that of the TAU group.  As anxiety affects 
around 25% of stroke survivors (Townend et al., 2006), this result is disappointing and will 
require further investigation.  All outcome data were based on self-report measures, which 
is another limitation.  As this study was a pilot study, not a clinical trial, the authors were 
unable to control for use of concomitant treatments and were also unable to gather data on 
the stroke survivors invited to the study by the clinical teams but declined to participate.  
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The type of participants that are willing to engage in group format psychological 
interventions, as opposed to individual therapy or medication only, may lead to a self-
selected sample, which may in turn skew research outcomes (Wylde et al., 2014).  It is 
recognised by the authors that a group setting may be sub-optimal for some patients and 
therefore referring professionals and course facilitators need to consider a range of 
interventions, tailored to patient need (Royal College of Physicians, 2016).  Due to the 
resources available, this study was unable to: provide equality of therapy hours for the 
control group, compare against an active treatment or undertake checks for treatment 
adherence and therapist competence.  All of which are outlined by the psychotherapy 
outcome study methodology rating form (POMRF) as an indication of good study quality 
(Ost, 2008).   
 
Conclusions 
This pilot study was designed to consider the viability of studying a group-based ACT 
intervention for stroke survivors.  Since there is limited research on cost-effective low 
intensity psychological interventions for stroke survivors and reports suggest stroke 
survivors’ emotional wellbeing is being neglected, pilot studies such as this one are vital to 
progress our understanding of potentially effective and efficacious interventions.  The 
results of this current study should be seen as preliminary as the sample size was small in 
comparison to trials intended to produce conclusive results.  Recommendations for further 
research include a larger sample, with active comparison groups and to assess the cost-
effectiveness of this intervention.    
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Tables and Figures 
Table 1: Session-by-Session Outline of Activate Your Life after Stroke course 
Session Content 
Week one: 
You are not your mind 
Creating the distinction between actions that are under our own 
(conscious, deliberate) control and actions that are controlled by 
our mind (e.g. on ‘autopilot’) including experiences of self-
criticism and rumination.  Introduced the idea of developing a 
viewpoint from which one can observe thoughts and feelings, 
non-judgementally. 
Week two: 
Facing up to life 
Focus on acceptance (not resignation) and willingness to 
experience unpleasant feelings and sensations (e.g. pain or 
anxiety) without attempts to fight, avoid or suppress them, 
which often causes suffering long-term. 
Week three: 
Being mindful 
Thoughts are thoughts, not facts.  Several examples of thought 
defusion exercises presented.  Explanation of mindfulness and 
non-interactive activities completed (e.g. body scan). 
Week four: 
Living wisely, living well 
Identification of individual values, distinction between values 
and goals and examples of committed action discussed.   
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Figure 1: Flowchart of Participants in Randomised Groups 
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Table 2: Number of Group Members who took part in the research study 
 Group 1 (n) Group 2 (n) Group 3 (n) Group 4 (n) Total 
ACT 7 7 3 9 26 
CONTROL 4 6 7 10 27 
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Table 3: Participant Characteristics at Baseline (Mean (SD) or n (%)) 
Characteristics ACT (n=26) Control (n=27) Overall (n=53) P value 
Mean age (years) 65.3 (11.9) 60.0 (15.6) 62.7 (13.9) .184 
Gender (% male) 21 (80.8) 11 (40.7) 32 (60.4) .002* 
Has had more than one stroke 6 (23.1) 8 (29.6) 14 (26.4) .538 
Months since most recent stroke 14.1 (14.5) 13.1 (13.3) 13.6 (13.7) .824 
Months since first stroke (if had multiple) 62.5 (73.7) 40 (37.1) 50 (50.8) .380 
Age left education 18.5 (3.6) 17.0 (2.1) 17.8 (3.0) .090 
Currently employed 4 (15.4) 10 (37) 14 (26.4) .05 
Currently retired 19 (73.1) 13 (48.1) 32 (60.4) .124 
Living circumstance: 
   
.003 
              Living with carer 19 (73.1) 5 (18.5) 24 (45.3) 
               Living with someone who is not            
carer 3 (11.5) 12 (44.4) 15 (28.3) 
               Living alone 4 (15.4) 7 (25.9) 11 (20.8) 
 Has previously received treatment for a 
mental health condition since stroke 11 (42.3) 9 (33.3) 20 (37.7) .653 
Treatment received: 
   
.923 
               Medication 1 (3.8) 2 (7.4) 3 (5.7) 
                Psychological therapies 4 (15.4) 2 (7.4) 6 (11.3) 
                Both the above 3 (11.5) 1 (3.7)  4 (7.5) 
                Not stated 3 (11.5) 4 (14.8) 7 (13.2) 
 Study outcome measures at baseline 
                  PHQ-9  12.46 (6.3) 10.85 (7.5) 11.65 (6.9) .402 
              GAD-7 9.77 (6.2) 7.85 (6.6) 8.79 (6.4) .280 
              EQ-5D-5L  .65 (.26) .61 (.28) .63 (.27) .554 
              Health (EuroQoL visual analogue) 59.62 (20.5) 55.67 (23.8) 57.6 (22.1) .521 
              AHS 40.77 (14.3) 43.37 (13.3) 42.09 (13.7) .496 
              WEMWBS 40.31 (10.5) 42.37 (12.7) 41.36 (11.6) .522 
ACT=acceptance and commitment therapy, TAU=treatment as usual, SD = standard deviation, PHQ-9 = patient health 
questionnaire-9, GAD-7 = generalized anxiety disorder-7, EQ-5D-5L = Euro-quality of life, AHS = adult hope scale, WEMWBS 
= Warwick and Edinburgh mental wellbeing scale 
* =significant P value after Bonferroni correction (.05/17 = .0029) 
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Table 4: Means and Standard Deviation for all Outcome Variables 
    PHQ-9 GAD-7 EQ-5D-5L  
Health (Euro-QOL 
visual analogue) AHS WEMWBS 
T1 ACT 12.46 (6.3) 9.77 (6.2) .65 (.26) 59.62 (20.5) 40.77 (14.3) 40.31 (10.5) 
 
TAU 10.85 (7.5) 7.85 (6.6) .61 (.28) 55.67 (23.8) 43.37 (13.3) 42.37 (12.7) 
T2 ACT 9.31 (6.7) 6.42 (5.5) .68 (.22) 71.23 (17.2) 46.08 (10.3) 47.50 (12.0) 
 
TAU 9.93 (7.0) 6.37 (5.5) .65 (.24) 60.81 (22.8) 42.56 (13.3) 45.67 (12.4) 
T3 ACT 8.27 (6.5) 6.42 (4.9) .65 (.26) 69.23 (16.8) 46.38 (12.2) 48.69 (12.9) 
  TAU 9.74 (7.4) 6.59 (6.0) .70 (.19) 70.0 (20.49) 44.56 (13.0) 46.70 (14.7) 
T1= pre-intervention baseline, T2= post-intervention, T3=2 month follow-up, ACT=acceptance and commitment therapy, 
TAU=treatment as usual, PHQ-9 = patient health questionnaire-9, GAD-7 = generalized anxiety disorder-7, EQ-5D-5L = Euro-
quality of life, AHS = adult state hope scale, WEMWBS = Warwick and Edinburgh mental wellbeing scale 
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Figure 2: Line Graphs Illustrating Interactions for Each Outcome Measure between Groups 
across the Three Time Points 
 
Pre = pre-treatment baseline, Post = post-treatment, FU =2 month follow-up 
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Introduction 
This paper presents a critical appraisal of the research conducted for this thesis and is not 
intended for publication.  The appraisal will include a critical evaluation of both the 
systematic review and empirical study exploring the planning, implementation and 
interpretation of the research processes.  Strengths and limitations are explored and 
personal-professional reflections will be offered. 
 
Paper 1: Systematic Review 
Strengths and Weaknesses of the Research Process 
Rationale for Topic 
At the point of deciding on a review topic, I knew that my empirical study was an evaluation 
of a randomised controlled trial (RCT) of group-based Acceptance and Commitment Therapy 
(ACT) for stroke survivors.  I was also aware that there had been previous reviews of ACT 
across a variety of clinical settings (Graham et al., 2016; Ost., 2014; Ruiz, 2012; Swain, 
Hancock, Hainsworth, et al., 2013; Veehof et al., 2011; Veehof. et al., 2016).  However, many 
of the existing reviews mixed study populations and delivery formats i.e. children, adults, 
indirect (i.e. parents and staff groups), 1:1 and groups.  I wanted to contribute to this 
knowledge about the effectiveness of ACT whilst facilitating additional understanding with a 
specific focus of ACT being delivered as a group format.  To my knowledge, there are no 
other reviews reporting solely on the effectiveness of group-based ACT.  I felt that this was a 
particularly relevant review due to recent austerity measures and the desire for cost-
effective and accessible therapies, and innovative delivery formats, within healthcare 
settings (National Collaborating Centre for Mental Health, 2010).   
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Inclusion and Exclusion Criteria: Randomised Controlled Trials 
The decision was taken to include only RCTs in the systematic review because they are 
widely considered to be the “gold standard” for treatment efficacy studies (Shean, 2014) 
and therefore, systematic reviews of RCTs are considered to offer the highest level of 
evidence (Charrois, 2015).  The Cochrane Collaboration is particularly encouraging of 
systematic reviews of RCTs and recommends inclusion of nonrandomised studies only when 
RCTs are lacking (Peinemann, Tushabe, & Kleijnen, 2013).  Anecdotally, whilst reviewing full-
text reviews I noticed that this seemed to make a difference to the fidelity of the ACT 
intervention that was evaluated in the individual empirical studies.  For example, 
nonrandomised studies often included additional information and strategies alongside the 
ACT core principles (Goodwin, Forman, Herbert, Butryn, & Ledley, 2012; Lance M. 
McCracken et al., 2015; L. M. McCracken & Jones, 2012; Skinta, Lezama, Wells, & Dilley, 
2015; Vowles & McCracken, 2008).  Therefore, I feel that the exclusion of nonrandomised 
studies is a particular strength of this review. 
 
Inclusion and Exclusion Criteria: Long-Term Conditions 
I came to the decision of focusing this systematic review on physical health related long-
term conditions (LTCs) after several discussions with my academic supervisor.  We discussed 
a variety to potential ways to focus this review, for example: whether to include only 
neurological conditions in line with my stroke-based empirical study, or to include 
conditions with known aetiology such as cancer and type-2 diabetes and we considered 
several definitions of LTCs.  Due to the small numbers of RCTs published in the area we 
decided to be as inclusive as possible of all long-term physical health conditions, regardless 
of known aetiology, as research suggests that people experience chronic pain conditions as 
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just as disabling as conditions with known physiological aetiology.  Worldwide low-back pain 
is ranked as number one for years lost to disability out of 291 LTCs and the Global Burden of 
Disease study found that four of the top twelve most disabling conditions globally were 
chronic pain conditions (Hoy et al., 2014).  As outlined in paper one, just like other LTCs, 
chronic pain conditions are associated with decreased health status and quality of life, and 
an increased risk of depression and loss of employment (Breivik et al., 2013; Breivik. et al., 
2006).  Whilst I acknowledge that there are advantages and disadvantages to this approach, 
I believe that the inclusion of chronic pain conditions, including chronic headaches and 
fibromyalgia, is a strength of this review.  This approach has also been taken by a recent 
article regarding LTCs which has been published in the same journal that my review has 
been prepared for (Bogosian et al., 2016). 
  
Inclusion and Exclusion Criteria: Peer-Reviewed Articles 
When abstracts from Dissertation Abstracts International arose in my initial screening, I took 
advice from the University Librarian for the standard protocol for including them or not.  
The advice was to exclude them to ensure use of the ‘most rigorous possible evidence 
available’ (Appendix 20).  A weakness of this decision is that this could have introduced a 
publication bias as studies with significant or clinically favourable findings are more likely to 
be published, which could lead to an overestimation of the treatment effects (Dwan et al., 
2008).  However, unpublished studies may be of lower methodological quality than 
published studies (Egger, Juni, Bartlett, Holenstein, & Sterne, 2003) as the peer-reviewed 
process can act as a filter for poorly conceived or executed research (Ware & Monkman, 
2008).   
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Literature Search 
The literature search was conducted in line with the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) guidelines (Appendix 21) to ensure the 
search was systematic and transparent (Moher et al., 2009).  In order to identify the widest 
scope of primary research, a thorough and complete search of the literature is required and 
the best way to accomplish this is to seek assistance from a librarian with expertise in the 
area of systematic reviews in defining the search terms, search strategies, and databases to 
be used (Charrois, 2015).  Therefore, I contacted a Cardiff University librarian who assisted 
the development of the search terms and recommended databases to search.  This was 
particularly helpful for considering MeSH subject headings and truncation commands.  We 
discussed using specific or broad search terms for health conditions and decided that due to 
the vast number of possible LTC diagnoses and condition names, a broad search strategy 
would be paramount. 
 
I used an online software programme (www.covidence.org), which is recommended by 
Cochrane, as a screening and data extraction tool to streamline the process of systematic 
reviews.  I came across this software whilst assisting a PhD student as a second reviewer 
during my MSc and found it extremely useful for organising all of the potential studies, 
screening abstracts and full texts, and resolving disagreements.  Therefore, I recommended 
this software to my doctorate cohort peers which received positive feedback.  Since having 
two reviewers is a recommended to enhance objectivity and reduce the possibility of 
rejecting relevant studies (Liberati et al., 2009), I paired up with a peer to act as second 
reviewers for one another’s reviews.  We decided to second review 100% of each other’s 
abstracts, full-text articles, data extraction and study quality.  This software helped us to 
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clearly separate the two reviews and eliminate confusion which I believe reduced errors in 
our screening processes.  I created a data extraction form and a study quality spreadsheet 
for this review to provided standardisation, and eliminate discrepancies, between the two 
reviewers (Charrois, 2015).  Several authors were contacted for missing information, 
however no responses were received and therefore, some data are missing as identified in 
table two in paper one and within the body of the data synthesis.  Since many of the 
reviewed studies used various different outcome measure tools, a meta-analysis was not 
possible however, systematic reviews can still be highly relevant and useful without pooled 
data (Charrois, 2015). 
 
Quality Assessment 
I found the process of choosing a quality assessment tool confusing as there does not 
appear to be a ‘gold standard’ or recommended tool.  I considered both the Critical 
Appraisal Skills Programme (CASP) (2015) and the Specialist Unit for Review Evidence (SURE) 
(2013) tools.  Whilst they both ask relevant questions regarding study quality, they have 
limited options to address the answers sensitively.  The options to answer a question such 
as ‘Was the assignment of patients to treatments randomised?’ are ‘yes’, ‘can’t tell’, ‘no’, 
therefore this creates limited distinction regarding processes that are the completed vs. 
processes that are completed well and to high standard.  They do provide you with ‘hints’ to 
consider each question in more detail, however this only provides qualitative information 
which makes it difficult to compare quality across studies.  Therefore, the Psychotherapy 
Outcome Study Methodology Rating Form (POMRF) was chosen as it was designed to 
provide a rating of the methodological stringency and quality of the third wave 
psychotherapies, such as ACT (Ost, 2008).  It was also found to have good internal 
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consistency (Cronbach’s α = .86) and good interrater-reliability (intra-class correlation = .92) 
(Ost, 2008).  I believe that using this quality tool was a strength of the systematic review as 
the tool encouraged clear distinction between levels of methodological rigour as each item 
is rated on a 3-point scale from 0 to 2, where 0 = poor, 1 = fair and 2 = good.   This 
quantitative approach also allowed for a total score to be calculated for each study.  Whilst 
these total scores are not attributed to overall qualitative meanings or categories of ‘poor’ 
or ‘good’ quality studies, they do allow for studies to be easily and directly compared to one 
another and against the mean of all the studies under review.  It was valuable to have the 
second reviewer to rate all of the studies for quality against this tool as it was an arduous 
task and human error was likely.  Discrepancies in scores were found for individual items 
and these were discussed until a consensus was reached.  I considered whether I should set 
a minimal methodologic quality for review inclusion, however I decided setting a minimum 
overall total score was too subjective.  I could not find any other reviews where this had 
been implement with this tool and I could not find any guidance on what total overall score 
deemed the study to be worthy of exclusion.  Therefore, I decided it would be more 
appropriate to review all of the studies, whilst ensuring transparency of study quality 
throughout.  Often, the main area of difficulty for researchers is how to incorporate this 
quality information into the data analysis (Charrois, 2015).  I hope that by providing the total 
scores in table two, qualitative categories in the narrative synthesis i.e. ‘a higher than 
average study found that...’, and the individual item scores in the appendix, this has been 
achieved appropriately. 
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Specific Implications for Theory and Clinical Practice 
ACT is still a relatively new therapy and has had a recent surge of publications across 
multiple clinical populations.  Nine of the twelve reviewed studies were published in the last 
five years.  In comparison to Cognitive Behavioural Therapy (CBT), ACT still has some way to 
go in order to produce a similar level of evidence.  However, I believe that this systematic 
review has highlighted that group-based ACT has utility as a low-intensity intervention in 
healthcare settings, particularly as it is the first review of its kind and has demonstrated 
promising findings.  Group-delivered therapies based on alternative psychological theories 
are already used widely across community healthcare settings, such as CBT, mindfulness and 
Dialectical Behavioural Therapy (DBT).  Therapies that can be delivered in a cost-effective, 
short term approach are of interest to Governments looking to commission such services in 
order to comply with national and international recommendations to increase the 
accessibility of evidence-based psychological therapies (Kuipers Cavaco & Quoidbach, 2014; 
National Collaborating Centre for Mental Health, 2010).  I believe that ACT could be 
particularly successful due to the trans-diagnostic nature of the theory (Lang et al., 2012).  It 
contrasts with group-based CBT, for example, patients are referred, based on a diagnosis, to 
different courses such as ‘anxiety management’ or ‘low mood’.  The CBT courses teach 
different strategies dependent on the diagnosis or presenting problem, which logistically 
will cost health services more as staff will require additional training to cover all techniques 
and multiple courses will need to be facilitated requiring increased staff time and venue hire 
costs.  This is in contrast to ACT which provides the similar information and strategies for all 
presenting problems thus reducing facilitation costs as fewer courses, for the same number 
of patients, would be required.  It is hoped that this systematic review will highlight the 
potential of group-based ACT in providing cost-effective, low-intensity and accessible 
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psychological input; will encourage further research; and will increase knowledge and 
interest in the theory of ACT and its clinical utility. 
 
Suggestions for Further Research 
Recommendations for further research are outlined in the systematic review regarding: 
 General topics to address where current evidence is lacking i.e. assessment of cost-
effectiveness. 
 Enhanced quantity of empirical studies i.e. more studies are required with LTCs 
samples to conduct a meta-analysis and draw firm conclusions about the 
effectiveness of group-based ACT for specific conditions and chronic health more 
generally.   
 Enhanced study quality is needed, such as active treatment comparison groups. 
 
As recommended by the university course tutors, once my systematic review was 
completed I submitted it to a journal.  I had prepared the review in accordance to the 
author guidelines and, rather optimistically, submitted it to the Clinical Psychology Review 
which has an impact factor (2015) of 8.146.  I chose this journal as a similar review had 
recently been published in it (Graham et al., 2016).  I received the following feedback from 
the Editor: 
“Unfortunately, the literature is quite sparse and the wide range of procedures 
and conditions studied precludes meaningful conclusions. I suggest you consider 
submitting the manuscript to a behavioral health journal that would be receptive 
to an exploratory report.” 
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I agree that the studies within the review do use a wide range of procedures and conditions 
which means it is difficult to draw firm conclusions regarding the effectiveness of group-
based ACT.  However, these early stage systematic reviews are important to identify these 
gaps in the knowledge base which can promote further research.  Agencies who grant 
funding for empirical studies often require justification for these additional studies in the 
form of a systematic review (Moher et al., 2009).  Therefore, I believe that this systematic 
review still plays a relevant and interesting role in shaping our knowledge about group-
based ACT for LTCs and the requirements necessary for future research.  My academic 
supervisor and I have agreed to submit the review to the British Journal of Health 
Psychology (impact factor: 2.895) and the review has been re-prepared to align with these 
journal guidelines which is the version submitted as paper one.  This mostly involved 
reducing the word count in the main body of the text, excluding tables, figures and 
references, from over 6,500 words to less than 5,000 words.  Now that this this process has 
been completed, I feel that this was a worthwhile task as the review is now more succinct 
and concise. 
 
Paper 2: Empirical Study 
Strengths and Weaknesses of the Research Process 
Rationale for Topic 
I have always had an interested in clinical health psychology, initially developed pre-training 
whilst working in an IAPT service in England implementing a LTCs pathway for adults with 
diabetes, cardiac disease, chronic obstructive pulmonary disease, and weight management 
difficulties.  I also co-facilitated group sessions for adults with chronic fatigue syndrome/ME.  
It was these clinical experiences that opened my mind to the psychological impact of LTCs.  I 
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learnt from patients’ stories about the circular nature of this issue: living with a LTC, and its 
consequences, caused many to feel low in mood and anxious whilst psychological distress 
impacted peoples’ ability to accept and effectively manage their illness.  I remember 
delivering CBT-based stress management sessions during cardiac and pulmonary 
rehabilitation programmes and feeling uncomfortable about facilitating thought challenging, 
as many of their LTC-relevant thoughts were accurate, e.g. “I can no longer work and 
provide for my family” or “I cannot walk more than a few metres before being completely 
out of breath”.  I remember feeling like it was somewhat unhelpful to suggest that they 
should think differently when their thoughts reflected their reality.  Although I value CBT 
ideas and use it regularly in clinical practice, I remember wondering if there was a more 
helpful way to approach psychological distress derived from physical health conditions.   
 
Following on from this IAPT post I completed a health psychology MSc prior to starting this 
clinical doctorate.  This MSc experience enabled me to consider the wider national and 
international public health context of LTCs and the importance of supporting people to take 
wise actions towards preventing, living with, and managing, their health condition to 
prevent premature mortality and to reduce morbidity.  In addition, I learnt about the 
multifaceted burden on healthcare systems to support patients with LTCs.  Since starting 
this clinical doctorate, we had introductory teaching on Acceptance and Commitment 
Therapy (ACT) which immediately interested me.  Therefore, when the opportunity 
presented itself to evaluate the effectiveness of group-based ACT for stroke survivors I was 
feeling very motivated to engage with this research and to play an active role in the service 
development that was required to implement this group intervention across four sites.  I 
was particularly keen to investigate alternative approaches, beyond CBT, for physical health 
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settings.  Also, having come from England IAPT into Wales’ services, I was very surprised at 
the lack of primary care mental health services.  I was aware of the ‘Activate your Life’ 
courses, which alongside ‘Stress Control’ (White, 2005, 2010), appeared to me to be Wales’ 
answer to IAPT and primary care.  This is particularly relevant in the Welsh context, where 
over half of the study participants were recruited, as three of the seven NHS health boards 
were among the top 10% of primary care trusts across England and Wales for high rates of 
antidepressant prescribing (Roberts & Sedley, 2016).  Furthermore, several systematic 
reviews have concluded inconsistent and disappointing results regarding the effectiveness 
of psychological therapies (problem solving, goal setting, psycho-education and social 
support) for stroke survivors (Hackett, Anderson, House, & Halteh, 2008; Hackett, Anderson, 
House, & Xia, 2008; Sugavanam et al., 2013).  Therefore, I was excited by the idea of 
expanding knowledge of the effectiveness of low-intensity psychological interventions 
within NHS Welsh contexts. 
 
Quantitative Approach 
Originally, in the early research development stage I was planning to facilitate focus groups 
alongside gathering the quantitative outcomes so that the empirical study could also report 
on qualitative data from attendees of the ACT intervention to gain their experiences of the 
course, and what they liked and disliked about attending the course.  I was particularly 
interested to consider if the course materials and delivery format was acceptable to the 
stroke survivors as a psychological intervention and if they felt it had made a difference to 
how they related to their stroke and its consequences.  Finally, I would have been interested 
to know if they would recommend the intervention to a friend and if they had any 
suggested changes.  Qualitative methods can capture information which quantitative data 
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cannot about beliefs, values and feelings and can be used to learn from participants, to 
understand what is important to them, provide a context to apply meaning on quantitative 
results and to identify factors necessary to consider for future research (Berkwits & Inui, 
1998).  Although I feel this information would have provided an important layer to 
understand the findings in the empirical paper, after discussion with my academic 
supervisor and professional mentor it was decided that a single methodological approach 
was most practical than a mixed methods approach.  The stakeholders involved in the 
research, (the stroke units’ clinicians, course facilitators, the charity manager, Prof. Neil 
Frude who wrote the course and the service users) had engaged in the research on the 
initial understanding that the aim was to evaluate the course using a quantitative design 
which in turn could provide information useful for enhancing service delivery, for example, 
in future commissioning bids.  Therefore, I decided to conduct a purely quantitative 
approach and a colleague from my cohort completed the qualitative research so that the 
evaluation of this ACT intervention could be completed in more depth across two LSRP’s. 
 
ACT Intervention 
The group-based ACT intervention for stroke survivors ‘Activate Your Life After Stroke’ was 
an adapted version of Professor Neil Frude’s ‘ACTivate Your Life’ course (Cartwright & 
Hooper, in press) which has been facilitated since 2015 as a tier 0 primary care service 
across a number of health boards across south Wales alongside Jim White’s ‘Stress Control’ 
(White, 2005, 2010) and Chris Williams’ ‘Living Life to the Full’ (2007).  There is no booking 
system for the original ACTivate Your Life course.  The course is advertised in community 
venues such as GP practice surgeries and often recommendations are made by GPs or other 
health professionals.  However there is no formal referral system and interested people can 
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just arrive to the first session.   This course is delivered in several community venues across 
south Wales and is offered on a variety of days and times to increase access.  A service 
evaluation was conducted of outcomes from 117 individuals who had attended at least one 
session.  Significant positive differences were found from pre-treatment to post-treatment 
on measures of anxiety, depression, self-esteem, wellbeing, mindfulness-based self-efficacy 
and psychological flexibility (Cartwright & Hooper, in press).   This course also has the 
support from the co-founder of ACT, Steven Hayes (Appendix 22).   
 
Service User Involvement 
This research has been a vehicle for the shared engagement and activation of clinical staff 
and service users.  During the adaptation process of the already existing ‘ACTivate Your Life’ 
course, service users played a key role.  Their role was imperative to ensure the course 
material had relevant and appropriate stroke examples throughout as well as giving 
guidance on the presentation slides to reduce words and contrasting colours on the screen 
that would affect stroke survivors with aphasia.  Being part of the truly collaborative process 
was extremely interesting as they gave feedback on things that I would never have 
considered, such as distracting swirling PowerPoint backgrounds that may have otherwise 
acted as a barrier to many stroke survivors attending to the course material. 
 
Power Analysis and Sample Size Calculation 
A power analysis was conducted prior to recruitment using G*Power (Faul et al., 2007) as an 
approach to calculate the required sample size.  The statistical power of a study is 
influenced by multiple factors, such as the sample size, the study design, the number of 
conditions, the size of the effect being measured  (Akobeng, 2005). Completing a power 
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analysis prior to recruitment can inform the researcher as to the required sample size in 
order to maximise the chance of answering the research question (Akobeng, 2005).  When I 
completed the quality assessment tool for the systematic review, I noticed that many of the 
RCTs had not explicitly reported conducting a power analysis to inform their goal of 
recruitment figures.  This is a failing, as when sample sizes are too small it reduces the 
chance of detecting any true differences between the groups.  Therefore this would be a 
waste of resources, participants’ time and may be unethical (Akobeng, 2005).  Therefore, it 
is a strength of this empirical study that a power analysis was conducted in the planning 
stages so that enough participants could be recruited. 
 
Selection of Outcome Measures 
The outcome measures that were chosen were largely influenced by what the clinicians; 
stroke services and my academic supervisor were familiar with and already using.  Since my 
academic supervisor works clinically in stroke services and regularly conducts research with 
stroke survivors, he had a good grounding for which outcome measures were relevant and 
interesting.  However, on reflection, if I had conducted my systematic review prior to 
making this decision I may have considered using different outcome measures which align 
with already published papers.  In particular I may have used the Hospital Anxiety and 
Depression Scale (HADS) or the Beck Depression Inventory (BDI-II) instead of the Patient 
Health Questionnaire-9 (PHQ-9) to measure low mood as this was more widely used in 
previous studies and would help to facilitate any future meta-analyses.  As a Trainee Clinical 
Psychologist, I have become accustomed to using outcome measures that services regularly 
use and are easily accessible.  However, from a researcher’s perspective, I should have given 
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consideration to the existing evidence base; therefore this has been a useful learning point 
for future research. 
 
Advantages and Disadvantages of the Methodological Approach  
Double-blind RCT designs are widely considered to be the “gold standard” for treatment 
efficacy studies (Shean, 2014), therefore a disadvantage of the approach used for this 
empirical study is that it was not double-blind.  This is a consequence of using a treatment 
as usual or waiting list control group as participants and researchers knew which was the 
active condition and therefore could not be blinded.  However, an advantage of the 
methodological approach taken is that participants were randomised to treatment 
conditions which reduced allocation bias and minimises the risk of the known and unknown 
confounding factor (Akobeng, 2005).  As such, RCTs are considered to provide the most 
reliable evidence on the effectiveness of interventions (Akobeng, 2005).  The randomisation 
of participants resulted in the two groups being comparable at baseline on all outcome 
measures as illustrated in table two of paper two. 
 
A common criticism of RCTs is that participants usually have one diagnosis based on a 
uncomplicated DSM-related symptom criteria and rarely have comorbidities,  yet this is an 
unrealistic reflection of the individuals who actually seek psychological services in the 
general population (Shean, 2014).  It is estimated that only 20% of people accessing 
psychological input have a single, uncomplicated diagnosis (Westen, Novotny, & Thompson-
Brenner, 2004).  Since ACT is trans-diagnosis (Lang et al., 2012), participants in this study 
were not included or excluded based on a diagnostic criteria thus this increases the external 
validity of the findings.   
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All of the measures used in this study were self-reported which can be problematic.  
Although all of the outcome measures used have good reliability and validity and are widely 
used, as outlined in paper two, self-reported measures rely on a certain level of self-
reflection which suggests this could lead to a response bias.  In addition, as the allocated 
treatment conditions could not be concealed from the participants, this may have increased 
the likelihood of social desirability influencing the outcomes whereby participants in the 
treatment group, may have presented their outcome responses in a favourable light, or 
‘faked good’ to gain social approval (van de   Mortel, 2008) as they would have known from 
the study’s participant information sheet (Appendix 5) that the aim was to assess if the ACT 
group was effective. 
 
A disadvantage of the way this study was conducted is that the stroke survivors in either 
group were not asked to report information that may have acted as confounding variables 
and possibly created biases to the study findings.  This includes information such as: their 
medication use and any changes to it, any contacts with healthcare professionals or 
services, other diagnoses, or adverse events that may have occurred over the study time 
period.  However, collecting this vast amount of data would have been a complex challenge 
for a pilot study with one researcher. 
 
Analysis   
The ACT model is trans-diagnostic (Lang et al., 2012), meaning the theories’ philosophy and 
strategies can be relevant for everybody and are not diagnostic-specific.  It is well 
documented that the consequences of having a stroke affects the stroke survivor’s loved 
ones who often go on to become the stroke survivor’s official carer.  A Stroke Association 
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survey (2013) found that 69% of carers experienced stress, 79% experienced anxiety, 84% 
experienced frustration and 60% experienced anger.  Therefore, carers were invited to 
attend the group alongside stroke survivors and, if they wished, to be involved in the 
research.  Twenty-four carers were recruited into the study (intervention group N = 15, 
control group N = 8) and were randomised in pairs alongside the stroke survivor for 
logistical reasons and to reduce contamination of the intervention materials to the control 
group.  Their data was collected using the same methods as the stroke survivors across the 
three time points as outlined in paper two.  The plan had been to analysis stroke survivor 
and carer data simultaneously.  However, during initial data screening an independent 
samples t-test was conducted with Bonferroni correction, to compare the groups at 
baseline.  Significant differences were found for the carers’ data, demonstrating that the 
treatment and control groups were significantly heterogeneous at baseline, as illustrated in 
table one below.  The carers’ scores in the intervention group were very low for distress, 
creating a “floor effect”.  This skewed the overall data when stroke survivors’ and carers 
data were analysed together making the overall treatment groups significantly 
heterogeneous at baseline.  However, when the carers’ data were removed, the stroke 
survivors’ data became comparable at baseline between treatment groups, as 
demonstrated in table two of paper two.  The decision to remove all of the carer data from 
the analysis was discussed with my academic supervisor and statisticians in the data clinics 
and we were all in agreement that since the course was originally designed for stroke 
survivors and they were the participants who had been primarily randomised into treatment 
groups it made sense to focus the analysis on these participants only.  
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Table one: Carer data at baseline (Mean (SD)) 
Measure 
Intervention 
N = 15 
Control 
N = 8 
P value 
Depression PHQ-9 3.53 (4.307) 11.00 (6.880) .005* 
Anxiety GAD-7 3.13 (3.461) 9.38 (6.844) .008* 
* = Significant P value after Bonferroni correction (.05/2= .025) 
 
The differences in carer data may have been caused because they were not officially 
randomised, unlike the stroke survivors.  For example, several carers had decided to attend 
the course as they had to physically bring the stroke survivor anyway and decided that it 
would make sense to stay rather return shortly afterwards to collect them.  Therefore, 
motivation to attend the course may have been linked to reasons other than wishing to 
access the psychological support for themselves.  This may also explain why there were 
nearly double the numbers of carers in the intervention group than in the control group.  I 
believe that making the decision to focus the analysis purely on stroke survivors was the 
right choice for this research because: 
 The stroke survivors were the primary focus for the adapted ACT material. 
 Stroke survivors had been the participants formally randomised into treatment 
groups, not the carers. 
 The stroke survivors were experiencing psychological distress as per baseline 
measures in table two, paper two.  However the carers in the intervention group 
were not, as illustrated in table one above. 
 The stroke survivors’ data was comparable at baselines between the two treatment 
groups as demonstrated in table two, paper two once the carer data had been 
removed. 
105 
 
 There were enough stroke survivors recruited to ensure the study had adequate 
power when the carers’ data was removed from the analysis. 
 
This decision was not addressed in paper two due to the finite word limit imposed by the 
journal as well as a desire to ensure a clear and concise narrative throughout the paper. 
 
Intention to Treat Analysis  
An intention to treat (ITT) analysis was used as per CONSORT guidelines (Schulz, Altman, & 
Moher, 2010) and as a result of conducting the POMRF quality measure (Ost, 2008) during 
the systematic review.  I developed an awareness that an ITT analysis can add to the quality 
of the paper as it accounts for noncompliance and missing outcome data through including 
every participant according to the randomised treatment assignment (Gupta, 2011).  ITT 
analysis is often described as “once randomised, always analysed” (Kruse et al., 2002) and 
can reduce bias as participants who drop-out may do so as an adverse response to the 
treatment  (Gupta, 2011).   Furthermore, ITT analysis protects the sample size from 
dropouts which, in turn protects the statistical power of RCTs (Gupta, 2011).  As ITT analysis 
is a cautious approach, it reduces the chance of a type I error.  However critics have 
suggested that ITT analysis may be more susceptible to type II error (Fergusson, Aaron, 
Guyatt, & Hebert, 2002).  Critics of ITT analysis suggest that analysing participants’ data who 
have dropped out of treatment can dilute treatment effects,  introduce heterogeneity 
within treatment groups, and participants who received very little of the treatment itself 
before dropping out provides insufficient information regarding the efficacy of any 
treatment (Heritier, Gebski, & Keech, 2003).  However these criticisms of ITT have limited 
application for this empirical study as all 26 participants in the group-based ACT 
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intervention attended at least three of the four sessions and 19 (73.1%) attended all four 
sessions.  Whilst care was taken to reduce missing data and dropouts, this was very difficult 
to avoid completely due to the clinical nature of this research and that I was working alone 
collecting data for 53 participants (plus the 24 carers as mentioned above), over three time 
points.  The last value carried forward approach was used for imputation of missing data 
across the six outcome variables.  This approach replaces missing data with the last known 
value before the participant dropped out of the study.  Criticism of the last value carried 
forward approach argue that it assumes that the outcome data at the point of dropout 
remains frozen or stable over the remaining study time points which is unrealistic and can 
introduce bias (Saha & Jones, 2009).  However, this method for dealing with missing data is 
one of the most commonly used approaches and it is the common practice in the psychiatric 
literature (Saha & Jones, 2009).  A review of the use of ITT analysis across 403 articles found 
that of the 249 (62%) articles which did report the use of ITT, the last observation carried 
forward imputation strategy was the most frequently used (Gravel, Opatrny, & Shapiro, 
2007).   
 
Use of a Multivariate ANOVA 
Mixed-design repeated measures multivariate ANOVAs were used to analyse the interaction 
between the groups.  This was used to assess the PHQ-9 as the primary outcome and the 
other five outcome measures as secondary outcome variables, across the three time points.  
This approach was chosen over conducting individual ANOVAs for each outcome variable as 
the multivariate ANOVA takes into account the inter-correlations amongst the dependent 
variables and the combination of variables is therefore more meaningful.  In addition, 
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repeating multiple ANOVAs can result in a Type I error due to multiple comparisons and 
therefore this approach is not recommended. 
 
Write up 
This empirical study was written up in line with the CONSORT checklist guidelines (Schulz et 
al., 2010) which are outlined in Appendix 23. 
 
Specific Implications for Theory 
As this is the first RCT of group-based ACT for stroke survivors, to the authors’ knowledge, 
the implications for the ACT theory is that this empirical study demonstrates that ACT can 
have utility in this clinical sample, which until now was an unknown quantity.  Although ACT 
theory suggests that its primary aim is not to reduce psychological distress, but instead to 
help people to live a valued life despite experiencing painful thoughts, feelings or sensations 
(Harris, 2013), this study has shown that this ACT intervention can make significant and 
clinical changes to patients levels of low mood as well as significantly improve their self-
rated health status and hopefulness.  This relationship between ACT and hopefulness 
requires further investigation to consider the implications for the theory more generally. 
 
Suggestions for Further Research 
Although preliminary, these findings suggest that a full RCT of ACT for stroke survivors 
would be viable and could provide confirmation of its efficacy.  One recommendation in the 
systematic review was that an active treatment comparison group would provide valuable 
information as the review found that, in general, ACT was more effective than treatment as 
usual and equally as effective as other active treatments such as cognitive bahavioural 
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therapy and relaxation training for people with a range of LTCs.  Suggested active treatment 
comparisons would be the current NICE recommended psychological therapies for stroke: 
motivational interviewing, problem solving and behavioural therapy (Royal College of 
Physicians, 2016).  These active comparison groups should also provide equality of 
treatment hours in order to protect against non-specific therapeutic factors.  Examples of 
this may be that attending the group, regardless of intervention model, allows participants 
to meet people who have had similar experiences.  This can stimulate a shared group 
identity, peer learning and enhance acceptance of chronic illness (Chambers et al., 2012), 
which in turn can decrease isolation, enhance emotional support, buffer against stress, 
and provide opportunities to gain knowledge (Nicholas, 2016).         
 
A future research suggestion is to use outcome measures that are more widely used in the 
LTCs literatures, as outlined in table two of paper one. The benefit of this is that it would 
increase the number of similar studies that could be compiled to conduct a meta-analysis to 
assess the effectiveness of group-based ACT for LTCs.  It is also recommended that future 
research evaluates the cost-effectiveness of group-based ACT.   
 
Specific Implications for Clinical Practice and Service Development 
The significant findings reported in this study are pertinent in relation to service delivery of 
psychological care within stroke units in the National Health Service across the UK.  
Psychological provision appears to be inconsistent, with more than half of stroke units 
reporting no access to psychology services at all  (Royal College of Physicians, 2012).  Whilst 
acknowledging that we had a relatively small sample size, I feel that these findings are 
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relevant for health settings, particularly in a time of austerity where prudent healthcare is 
key. 
 
This research was a vehicle for adding value directly into psychology services within the NHS 
and the participating charity.  All four sites have continual access to the course materials so 
that they can now facilitate the group as and when required to address service demands 
and several of the sites have facilitated the group independently since the end of data 
collection.  In particular for the charity involved, they have developed enhanced networks 
with the local NHS stroke team as a result of this study which involved the NHS stroke 
clinical team recruiting potential participants under a ‘participant identification site’.  In 
order to gain this NHS ethical approval for this site I met with the clinical stroke lead from 
the NHS team, alongside the charity’s operational manager to discuss how connections 
could be increased between the two organisations to enhance services for local stroke 
survivors.  Therefore, now that study has finished a lasting legacy has been left in all four 
sites to benefit clinical practice and service development. 
 
The current system for stroke survivors in the NHS involves a six week discharge programme 
with limited capacity from the (frequently sole) clinical psychologist in the service to offer 
more.  This is particularly important as the services cover vast geographical regions across 
south Wales.  The National Clinical Guidelines for Stroke suggest services should offer brief 
psychological interventions to all stroke survivors with, or at risk of, depression or anxiety 
and to plan for the long-term management of psychological distress (Royal College of 
Physicians, 2016).  Across the UK, 40% of stroke survivors felt abandoned after leaving 
hospital; 50% did not receive any information or support for anxiety or depression; and two-
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thirds said their emotional needs were not met as well as their physical needs following 
their stroke (Stroke Association, 2013).  Therefore, this group-based ACTivate your Life after 
Stroke course has been able to offer psychological input in the community beyond this usual 
six week discharge programme.  Whilst it is acknowledged that group-based interventions 
are not for everybody and outcomes will not always be optimal, this empirical study 
highlighted that it is acceptable and can have significant effects for many people.  This ACT 
course can be delivered by a range of presenters to a trans-diagnostic group of stroke 
survivors and it can produce significant outcomes.  This suggests that is has a large potential 
as a cost-effective intervention.  
 
Proposals for Dissemination 
I strongly believe in the importance of patients being protected from unnecessary research 
as well as benefiting from the subsequent improved outcomes and research informed care 
(Health Research Authority).  Therefore, I have written both the systematic review and 
empirical study to the specifications of the British Journal of Health Psychology (impact 
factor: 2.895, ISI Journal Citation Reports© Ranking: 2015: 21/122 Psychology Clinical).  
Beyond publication in peer-reviewed journals, I plan to disseminate my empirical study 
findings at the following conferences: 
• Division of Health Psychology Annual Conference 2017: Oral 
presentation (Accepted) 
• Division of Clinical Psychology Annual Conference 2018: Oral 
presentation (Submitted abstract: awaiting decision) 
• Welsh Stroke Conference 2017: poster presentation, see Appendix 24 
(Submitted abstract: awaiting decision) 
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• OPSYRIS Conference 2017: oral presentation (awaiting call for 
abstracts) 
 
In addition, once data analysis was completed I compiled a written summary to inform all of 
the stakeholders of the findings at the earliest opportunity as they were keen to know the 
outcomes so that they could continue to facilitate future groups. 
 
Personal-Professional Development Reflections 
Development of Research Ideas 
I feel that I have developed many research and clinical skills whilst conducting this research 
project.  During initial meetings with all stake holders, I quickly learnt that site 
representatives (i.e. clinical psychologists, charity operations manager and stroke care co-
ordinators) across the four sites (three NHS in south Wales and one charity in south west 
England) had their own expectations and priorities which had motivated them to engage in 
this research.  It was my role to think about how I could keep all four sites engaging in all 
aspects of the research collaboratively and simultaneously to reduce bias that might occur 
between sites.  In particular, three of the four sites had previously limited psychology input 
to cover vast geographical areas and were very eager to offer the course to as many stroke 
survivors as possible and as quickly as possible.  I learnt to retain a firm stance on the 
importance of randomising participants to both conditions which did mean that half of 
participants would get a delayed intervention (if they had been randomised to the control 
group).  I was aware of the charity being unable to randomise participants in previous 
research projects as they did not feel they could delay access to interventions which had led 
to heterogeneous treatment groups.  Therefore, in order to minimise anxieties regarding 
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the intervention delay, I was keen to have the second group organised and fully planned 
(e.g. facilitators agreed, dates and rooms booked, etc.) which started immediately after the 
two-month follow-up period of the first group.  This meant that as stroke survivors were 
randomised, clinical staff could give dates for either group which appeared to help with this 
process.  I found it was also helpful to provide information regarding how randomised 
controlled trials could provide useful findings that could help in future commissioning bids, 
which in turn could provide interventions for many stroke survivors in the future, beyond 
this research.  It was also beneficial to have full NHS ethical approval as the process of 
delaying treatment in the control group had been fully approved by the REC and R&D 
committees.  On reflection, I felt torn between my clinical and research stance and I had to 
frequently remind myself that I was involved within a research capacity and that I had to 
ensure that NHS time and resources were used to their best potential to produce a relevant 
and sound empirical RCT study to the best of my ability given the circumstances.   
 
Due to the constraints of conducting this research within the time scale of the doctorate 
course, I had applied for ethical approval for the empirical study and completed data 
collection before conducting my systematic review.  I found this extremely frustrating as the 
findings from my systematic review, particularly my quality assessment, could have shaped 
my empirical study.  I discussed this with my academic supervisor, which led to discussions 
regarding research run by clinical trials in comparison to what I could realistically achieve 
and that perhaps, actually, the empirical study would not have been very different, even if I 
had conducted the systematic review earlier.  For example, I would not have been able to 
provide an active treatment group comparison with the resources available.   
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Completing research within the NHS has been complicated experience.  The process of 
completing NHS REC ethical approval and authorisation from four R&D sites was extremely 
taxing whilst juggling additional demands from the doctorate.  On reflection I am very proud 
of this achievement.  This process was hugely helped by my MSc dissertation experience 
which had also required NHS ethical approval.  From this experience I had learnt small but 
useful tips such as dating all documents in the header with a version number so that myself 
and ethics committee had a clear trail of latest and updated documents.  This more recent 
ethics approval process for this empirical study helped me to develop organisational skills as 
the four individual R&D sites, plus the REC site requested different changes to different 
documents meaning I was managing five sets of documents, changes, and correspondences. 
 
Whilst collecting data from the control group who were not accessing any psychological 
input, I was curious regarding my clinical and ethical duty to action any information that was 
shared to me from participants, particularly regarding their safety.  Whilst collecting data 
over the telephone, one participant disclosed to me that they were experiencing suicidal 
thoughts.  I had explained my remits of confidentiality in the participant information forms 
(Appendix 5) and informed the participant I had a duty to pass on the information to the 
team’s psychologist, which they understood and I acted on immediately.  I felt torn between 
my clinical and research duties and had to remind myself of where my research duties 
ended and that I was not part of the participant’s clinical team.  This event highlighted the 
importance of having agreed pathways for how to act on this critical information and how to 
reach the psychologist involved to ensure participant safety.    
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During the data collection process, I was conscious of building a rapport with the 
participants, particularly the control group.  I was mindful that they were spending time 
completing several questionnaires over three time points, whilst not receiving any 
immediate intervention as a consequence.  I personally felt uncomfortable with this whilst 
also knowing in my academic mind that this is obviously the basis of an RCT with a control 
group and that they would be able to attend the course a few months later, if they wished.  
Every contact I felt a tension between being friendly and appreciative of their efforts but 
trying not to be drawn into their ‘stories’ some of them gave when answering the 
questionnaires.  I was very aware that I did not want to provide any sort of ‘intervention’, 
even active listening therefore I worked hard to hold this in mind so to not introduce bias 
when collecting data and I also encouraged responses to be returned by post by providing 
self-addressed stamped envelopes which seemed to work well. 
 
Professional Roles for Clinical Psychologists 
Working across the NHS and third sector organisations gave me a valuable insight into the 
process of implementing service developments.  The three NHS clinical psychologists simply 
did not have the time or resources to logistically organise the planning of the course for 
example, room bookings.  I took on the role of finding and booking free community venues 
such as local libraries and supermarkets whereas the charity had funds and resources to 
organise this themselves and pay for rooms.  This made me reflect upon the role of a clinical 
psychologist with the NHS and that it is an expectation that we are at the fore-front of 
service development, particularly when it comes to increasing access to psychological 
therapies.  However, given the high demands that are currently placed on public services, 
this can be difficult.  This seems counter-intuitive as setting up psychological groups means 
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that many people can access services, yet the NHS pressures meant that staff members 
understandably were too busy engaging in existing clinical demands to implement this 
themselves.   
  
Motivation for Future Research 
I have valued having the dedicated time to conduct this research and I am pleased that my 
findings have shown that this course has been of use to the participants.  Whilst on my 
elective placement, also in a health service, I co-facilitate mindfulness sessions for medical 
staff during their lunch breaks.  I am in the process of evaluating this and aim to write up the 
findings.  This added level of evaluation to my clinical practice and plans for potential 
dissemination have come from my newly developed skills in research as a result of 
conducting this LSRP.  I hope that once I qualify I will continue to hold formal evaluation and 
research in the fore-front of my mind, whilst I am also mindful of the time constraints and 
pressures that I am likely to face, that may act as a barrier.  This tension is something I plan 
to discuss in future supervisions and appraisals, if appropriate, as I feel research really does 
need dedicate time and resources to be worthwhile and useful.  
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• In normal circumstances, effect size should be incorporated. 
• Authors are requested to avoid the use of sexist language. 
• Authors are responsible for acquiring written permission to publish lengthy quotations, 
illustrations, etc. for which they do not own copyright. For guidelines on editorial style, please 
consult the APA Publication Manual published by the American Psychological Association. 
• Manuscripts describing clinical trials are encouraged to submit in accordance with the CONSORT 
statement on reporting randomised controlled trials. 
• Manuscripts reporting systematic reviews and meta-analyses are encouraged to submit in 
accordance with the PRISMA statement. 
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information with the online version of an article. Examples of Supporting Information include 
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nonessential multimedia files. Supporting Information should be cited within the article text, and a 
descriptive legend should be included. Please indicate clearly on submission which material is for 
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online only publication. It is published as supplied by the author, and a proof is not made available 
prior to publication; for these reasons, authors should provide any Supporting Information in the 
desired final format. 
For further information on recommended file types and requirements for submission, please visit 
the Supporting Information page on Author Services. 
7. OnlineOpen 
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available to non-subscribers on publication, or whose funding agency requires grantees to archive 
the final version of their article. With OnlineOpen, the author, the author's funding agency, or the 
author's institution pays a fee to ensure that the article is made available to non-subscribers upon 
publication via Wiley Online Library, as well as deposited in the funding agency's preferred archive. A 
full list of terms and conditions is available on Wiley Online Library. 
Any authors wishing to send their paper OnlineOpen will be required to complete the payment form. 
Prior to acceptance there is no requirement to inform an Editorial Office that you intend to publish 
your paper OnlineOpen if you do not wish to. All OnlineOpen articles are treated in the same way as 
any other article. They go through the journal's standard peer-review process and will be accepted 
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online and choose to receive automated e-mails at key stages of production. The author will receive 
an e-mail with a unique link that enables them to register and have their article automatically added 
to the system. You can then accessKudos through Author Services, which will help you to increase 
the impact of your research. Visit Author Services for more details on online production tracking and 
for a wealth of resources including FAQs and tips on article preparation, submission and more. 
9. Copyright and licences 
If your paper is accepted, the author identified as the formal corresponding author for the paper will 
receive an email prompting them to login into Author Services, where via the Wiley Author Licensing 
Service (WALS) they will be able to complete the licence agreement on behalf of all authors on the 
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For authors signing the copyright transfer agreement 
If the OnlineOpen option is not selected the corresponding author will be presented with the 
copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in 
the samples associated with the Copyright FAQs . 
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Appendix 2: Psychotherapy Outcome Study Methodology Rating Form (POMRF; Ost, 2008) 
Note: If not enough information is given regarding a specific item a rating of 0 is given. 
1. Clarity of sample description 
0 Poor. Vague description of sample (e.g. only mentioned whether patients were diagnosed with 
the disorder). 
1 Fair. Fair description of sample (e.g. mentioned inclusion/exclusion criteria, demographics, 
etc.). 
2 Good. Good description of sample (e.g. mentioned inclusion/exclusion criteria, demographics, 
and the prevalence of comorbid disorders). 
2. Severity/chronicity of the disorder 
0 Poor. Severity/chronicity was not reported and/or subsyndromal patients were included in 
the sample. 
1 Fair. All patients met the criteria for the disorder. Sample includes acute (o1 yr) and/or low 
severity. 
2 Good. Sample consisted entirely of chronic (41 yr) patients of at least moderate severity. 
3. Representativeness of the sample 
0 Poor. Sample is very different from patients seeking treatment for the disorder (e.g. there are 
strict exclusion criteria). 
1 Fair. Sample is somewhat representative of patients seeking treatment for the disorder (e.g. 
patients were only excluded if they met criteria for other major disorders). 
2 Good. Sample is very representative of patients seeking treatment for the disorder (e.g. 
authors made efforts to ensure representativeness of sample). 
4. Reliability of the diagnosis in question 
0 Poor. The diagnostic process was not reported, or not assessed with structured interviews by 
a trained interviewer. 
1 Fair. The diagnosis was assessed with structured interview by a trained interviewer. 
2 Good. The diagnosis was assessed with structured interview by a trained interviewer and 
adequate inter-rater reliability was demonstrated (e.g. kappa coefficient). 
5. Specificity of outcome measures 
0 Poor. Very broad outcome measures, not specific to the disorder (e.g. SCL-90R total score). 
1 Fair. Moderately specific outcome measures. 
2 Good. Specific outcome measures, such as a measure for each symptom cluster. 
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6. Reliability and validity of outcome measures 
0 Poor. Measures have unknown psychometric properties, or properties that fail to meet 
current standards of acceptability. 
1 Fair. Some, but not all measures have known or adequate psychometric properties. 
2 Good. All measures have good psychometric properties. The outcome measures are the best 
available for the authors’ purpose. 
7. Use of blind evaluators 
0 Poor. Blind assessor was not used (e.g. assessor was the therapist, assessor was not blind to 
treatment condition, or the authors do not specify). 
1 Fair. Blind assessor was used, but no checks were used to assess the blind. 
2 Good. Blind assessor was used in correct fashion. Checks were used to assess whether the 
assessor was aware of treatment condition. 
8. Assessor training 
0 Poor. Assessor training and accuracy are not specified, or are unacceptable. 
1 Fair. Minimum criterion for assessor training is specified (e.g. assessor has had specific 
training in the use of the outcome measure), but accuracy is not monitored or reported. 
2 Good. Minimum criterion of assessor training is specified. Inter-rater reliability was checked, 
and/or assessment procedures were calibrated during the study to prevent evaluator drift. 
9. Assignment to treatment 
0 Poor. Biased assignment, e.g. patients selected their own therapy or were assigned in another 
non-random fashion, or there is only one group. 
1 Fair. Random or stratified assignment. There may be some systematic bias but not enough to 
pose a serious threat to internal validity. There may be therapist by treatment confounds. N may 
be too small to protect against bias. 
2 Good. Random or stratified assignment, and patients are randomly assigned to therapists 
within condition. When theoretically different treatments are used, each treatment is provided 
by a large enough number of different therapists. N is large enough to protect against bias. 
10. Design 
0 Poor. Active treatment vs. WLC, or briefly described TAU. 
1 Fair. Active treatment vs. TAU with good description, or placebo condition. 
2 Good. Active treatment vs. another previously empirically documented active treatment. 
11. Power analysis 
0 Poor. No power analysis was made prior to the initiation of the study. 
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1 Fair. A power analysis based on an estimated effect size was used. 
2 Good. A data-informed power analysis was made and the sample size was decided 
accordingly. 
12. Assessment points 
0 Poor. Only pre- and post-treatment, or pre- and follow-up. 
1 Fair. Pre-, post-, and follow-up o1 year. 
2 Good. Pre-, post-, and follow-up X1 year. 
13. Manualized, replicable, specific treatment programs 
0 Poor. Description of treatment procedure is unclear, and treatment is not based on a publicly 
available, detailed treatment manual. Patients may be receiving multiple forms of treatment at 
once in an uncontrolled manner. 
1 Fair. Treatment is not designed for the disorder, or description of the treatment is generally 
clear and based on a publicly available, detailed treatment manual, but there are some 
ambiguities about the procedure. Patients may have received additional forms of treatment, but 
this is balanced between groups or otherwise controlled. 
2 Good. Treatment is designed for the disorder. A detailed treatment manual is available, and/or 
treatment is explained in sufficient detail for replication. No ambiguities about the treatment 
procedure. Patients receive only the treatment in question. 
14. Number of therapists 
0 Poor. Only one therapist, i.e. complete confounding between therapy and therapist. 
1 Fair. At least two therapists, but the effect of therapist on outcome is not analyzed. 
2 Good. Three, or more therapists, and the effect of therapist on outcome is analyzed. 
15. Therapist training/experience 
0 Poor. Very limited clinical experience of the treatment and/or disorder (e.g. students). 
1 Fair. Some clinical experience of the treatment and/or disorder. 
2 Good. Long clinical experience of the treatment and the disorder (e.g. practicing therapists). 
16. Checks for treatment adherence 
0 Poor. No checks were made to assure that the intervention was consistent with protocol. 
1 Fair. Some checks were made (e.g. assessed a proportion of therapy tapes). 
2 Good. Frequent checks were made (e.g. weekly supervision of each session using a detailed 
rating 
form). 
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17. Checks for therapist competence 
0 Poor. No checks were made to assure that the intervention was delivered competently. 
1 Fair. Some checks were made (e.g. assessed a proportion of therapy tapes). 
2 Good. Frequent checks were made (e.g. weekly supervision of each session using a detailed 
rating form). 
18. Control of concomitant treatments (e.g. medications) 
0 Poor. No attempt to control for concomitant treatments, or no information about concomitant 
treatments provided. Patients may have been receiving other forms of treatment in addition to 
the study treatment. 
1 Fair. Asked patients to keep medications stable and/or to discontinue other psychological 
therapies during the treatment. 
2 Good. Ensured that patients did not receive any other treatments (medical or psychological) 
during the study. 
19. Handling of attrition 
0 Poor. Proportions of attrition are not described, or described but no dropout analysis is 
performed. 
1 Fair. Proportions of attrition are described, and dropout analysis or intent-to-treat analysis is 
performed. 
2 Good. No attrition, or proportions of attrition are described, dropout analysis is performed, 
and results are presented as intent-to-treat analysis. 
20. Statistical analyses and presentation of results 
0 Poor. Inadequate statistical methods are used and/or data are not fully presented. 
1 Fair. Adequate statistical methods are used but data are not fully presented. 
2 Good. Adequate statistical methods are used and data are presented with M and SD. 
21. Clinical significance 
0 Poor. No presentation of clinical significance was done. 
1 Fair. An arbitrary criterion for clinical significance was used and the conditions were 
compared regarding percent clinically improved. 
2 Good. Jacobson’s criteria for clinical significance were used and presented for a selection (or 
all) of the outcome measures, and conditions were compared regarding percent clinically 
improved. 
22. Equality of therapy hours (for non-WLC designs only) 
0 Poor. Conditions differ markedly (>20% difference in therapy hours). 
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1 Fair. Conditions differ somewhat (10–19% difference in therapy hours). 
2 Good. Conditions do not differ (<10% difference in therapy hours). 
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Appendix 3: Table of Individual Papers Quality Ratings 
 
 
POMRF 
Item 
Gregg 
'07 
Kemani 
'15 
Luciano 
'14 
Lundgren 
'06 
Lundgren 
'08 
McCracken 
'13 
Mo'tamedi 
'12 
Mohabbat-
Bahar '15 
Nordin 
'12 
Shayeghian 
'16 
Wetherell 
'11 
Wicksell 
'13 
1 1 2 1 1 1 2 1 1 1 1 2 1 
2 / / / / / / / / / / / / 
3 2 1 1 1 1 1 1 1 1 1 1 1 
4 / / / / / / / / / / / / 
5 2 2 2 1 1 2 2 1 1 2 2 2 
6 2 2 2 2 1 1 2 2 2 2 2 2 
7 1 0 1 0 0 1 0 0 1 0 2 0 
8 1 1 0 0 0 0 0 0 0 0 0 0 
9 1 2 2 1 2 1 1 1 1 1 2 2 
10 2 2 2 1 2 0 1 0 2 0 2 0 
11 2 2 2 0 0 0 0 0 0 2 0 0 
12 1 1 1 2 2 1 0 0 1 1 1 1 
13 1 1 0 2 2 1 2 1 1 1 0 2 
14 0 2 0 1 1 1 0 0 1 0 1 2 
15 0 2 2 2 2 2 2 0 2 0 2 2 
16 0 2 1 1 1 1 2 0 0 0 2 1 
17 0 2 1 1 1 1 2 0 0 0 2 1 
18 0 1 0 1 1 0 1 0 0 0 1 1 
19 2 2 2 0 0 2 2 0 1 0 2 0 
20 2 2 2 2 2 2 2 1 1 2 2 2 
21 1 2 2 1 1 2 1 1 1 1 2 1 
22 1 2 0 2 2 0 0 0 2 2 2 0 
Total 22 33 24 22 23 21 22 9 19 16 30 21 
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Appendix 4: ACT Group Leaflet for Participants 
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Appendix 5: Participant Information Sheet 
 
Participant information sheet  
We would like to invite you to take part in a research study to help us learn more about how to 
support people after stroke.  There are two parts to this study, the details of which are explained 
below.  
Before you decide to take part, it is important for you to understand why the study is being done 
and what you need to do.  Please read this leaflet carefully. 
Take time to decide whether or not you want to take part - talk it over with your family and friends, 
or ask us if you would like things explained or need more information. 
Thank you for reading this! 
 
Part 1 of the Study 
What is the study? 
We understand that a stroke can be life-changing for some survivors and their carers. Many stroke 
survivors find that they feel anxious or low in mood.  We think that a model of therapy called 
Acceptance and Commitment Therapy (ACT) could be helpful in improving mood and well-being 
after stroke.  This study aims to determine if ACT is effective to stroke survivors and carers.  
ACT teaches people to accept what is out of our personal control. It is based on the idea that, 
generally, trying to rid ourselves of pain and distress only serves to increase it. The alternative then, 
is to accept it - but that doesn't mean being defeated or tolerating suffering.  ACT is about learning 
skills and ways of managing to make room for painful feelings, thoughts, and sensations - allowing 
them to be there, without having to struggle against them. But it is more than just this, it is also 
about committing to action that improves and enriches our lives. 
The aim of this project is therefore to look at how effective this therapy is in reducing levels of 
anxiety or depression, and improving well-being.  In order to evaluate the effectiveness of this 
therapy properly, people who register their interest to participate in this study will be randomly 
allocated into one of two groups.  Group one: will be invited to attend the ACT therapy course as 
soon as possible.  Group two: will first go on a waiting list to receive ACT and then will be invited to 
attend the ACT course at a later date. 
Why are you doing this? 
When conducting research, there are lots of factors that may lead to change in how a person feels, 
for example, a person may simply feel better with time. One of the ways in which we try to ‘control’ 
for things like time, is to also include a ‘control’ or comparison group in the study.  The people 
randomly allocated to the ‘control’ group serve as a comparison for the group that receive ACT.  The 
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two groups are assessed in the same ways. Therefore, any difference between the two groups can 
be attributed to the intervention itself.  The group assigned to the waiting list initially will then be 
invited to receive the intervention at a later date. 
What will the course be like? 
The course is a four week therapeutic course called ‘ACTivate Your Life After Stroke’.  It is very 
important that you can to commit to attend all four sessions of this course since the sessions are 
closely linked. The sessions will last two hours per week (except the first and last session which will 
be two and a half hours).  There will be a break included at the middle of each session. The layout of 
the sessions will be the same. There will be a presentation given and you do not have to contribute 
or speak at all if you do not wish to do so. We just ask that you listen to the session content with an 
open mind. 
Can both the stroke survivor and his/her carer/spouse take part? 
Yes! Either one, or both are welcome to attend, but we do ask that ALL participants come to ALL four 
sessions. 
What exactly is involved if I do agree to take part? 
If you decide to take part in the research there will be five questionnaires to complete. These should 
take no longer than 30 minutes in total.  Both carers and stroke survivors will be asked to complete 
the same questionnaires at the start of the course and on completion of the course.  We will ensure 
there is time to complete these questionnaires within the first and last session of the course.  We 
would also like you to complete these questionnaires again two months after you finished attending 
so we can see how the benefits of ACT have been maintained. We may contact you via the 
telephone or post to complete these forms for the final time if you are willing for this.   
If you are allocated into the waiting list group, we will ask you to complete the same questionnaires 
at the same three time points as the treatment group, as outlined above. This allows us to 
determine if ACT is better than no treatment.  When you do attend the course, with your 
permission, we will ask you to complete the questionnaires three more times, at the start and end of 
the course and two months after the course has finished, as above.  This will help us to evaluation 
the usefulness of the treatment. 
How will my information be used?  
The results of the research will be written up as a thesis and an article and submitted as part of a 
Doctorate in Clinical Psychology.  It is important that you know that no participants will be identified 
in any way as part of this process.  
Do I have to take part? 
There is absolutely no requirement to participate in the research, and if you wish to join the course 
but not take part in the research you will still be welcomed as a valuable member.  Whether you 
chose to participate in the study or not, this will have no impact on your treatment you receive from 
the stroke team.   
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If I agree to participate in the study, can I change my mind later on? 
Yes, if you wish to withdraw from the study you can do this at any time.  All your identifiable 
information and data collected from you, to date, will be destroyed and your name removed from all 
study files. 
Will my participation in the study be confidential? 
Your participation in the research will be kept strictly confidential.  The questionnaires will be seen 
only by myself and my research supervisor (Reg Morris) and will be kept in a locked filing cabinet and 
identifiable information will be destroyed after 2 years. 
I have a duty of care to protect people from harm, so there are some legal and ethical rules I must 
obey which could require me to over-ride confidentiality in the very unlikely event that there is a risk 
of harm. 
Will I be paid for this study? 
There is no payment for taking part in this study. 
Who has reviewed the study? 
This study has been reviewed by the London - City & East Research Ethics Committee.  This means 
that the study processes involving the questionnaire data collection have been reviewed and given a 
favourable opinion by this NHS ethics committee (reference: XXXXX). 
The second part of the study involves Stroke Survivors and will take place once the “ACTivate Your 
Life After Stroke” course has finished.  We hope to learn more about the effectiveness of this 
psychological intervention by asking you some questions and exploring your personal views and 
experiences of the group.  
We will invite some of you (25) to a short interview, approximately 45 minutes, in a location 
convenient to you.  If you are keen to participate and would like to share your experiences of the 
group, or would like to know more information before consenting, please speak with your group 
facilitator.  They will happily provide you with a participant information sheet detailing part 2 of the 
study in more depth, ensuring you are fully informed before making your decision.  
Further information 
If you have any further questions about taking part in the study or need further information please 
do not hesitate to contact the researcher (contact details below). 
Thank you very much for taking the time to read this information sheet, your help is greatly 
appreciated.  If you would like to participate in this study, please let your stroke clinician know. 
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If you would like more information about the project, please feel free to contact us: 
Researcher: 
Sarah Harris 
Trainee Clinical Psychologist, Postgraduate student. 
South Wales Doctoral Programme in Clinical Psychology 
11th Floor, School of Psychology, Tower Building, 
70 Park Place, 
Cardiff, 
CF10 3AT 
Email: sarah.harris7@wales.nhs.uk 
Tel: 029 2087 0582 
 
Academic supervisor: 
Prof. Reg Morris 
Consultant Clinical Psychologist 
South Wales Doctoral Programme in Clinical Psychology 
Cardiff & Vale UHB 
Email: Reg.Morris@wales.nhs.uk 
Tel: 029 2020 6464 
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Appendix 6: Consent Form  
 
Consent form 
 
Please read each statement below, and put your initials in the appropriate Yes or NO response 
e.g.  
 
 
 
I understand that my participation in this study is entirely voluntary and that I 
can stop attending the sessions, or filling out the questionnaires at any time, 
without giving a reason. 
 
 Yes 
No  
 
 
 
I understand that I am free to ask questions at any time. I am free to discuss my 
concerns with Professor Reg Morris, consultant Clinical Psychologist and 
Programme Director on the South Wales Doctoral Programme in Clinical 
Psychology. 
 
 
 Yes 
No  
 
 
 
 
I understand that the information provided by me will be held confidentially, 
such that only the researcher can trace this information back to me individually. 
The identifiable information will be retained for up to 2 years then it will be 
destroyed. 
 
 
 Yes 
No  
 
 
 
I understand that agreeing to participate in this research; I may be allocated 
onto the waiting list control group meaning I will have a wait before I can 
access the treatment group. 
 
 Yes 
No  
 
 
 
 
 
 
 
 
KP 
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I,______________________                                 (please enter your NAME) consent to participate 
in the study conducted by Sarah Harris, who is working under the supervision of 
Professor Reg Morris. 
 
Signed (participant): _________________________________________________  
 
Date: _____________________________________ 
 
Please delete as appropriate: I am a stroke survivor /carer 
 
 
 
If verbal consent gained by participant, clinician to put initials in the box: 
 
 
Signed (clinician): _________________________________________________ 
 
Name (clinician): _________________________________________________ 
 
Date: _____________________________________ 
 
 
 
 
 
I understand that my participation in this study will involve completing five 
questionnaires, which should take no longer than thirty minutes and I may be 
asked to complete these questionnaires up to six separate occasions.  
 
 Yes 
No  
 
 
 
 
I give permission for the information to be used in reports with the 
understanding that it will be anonymous (i.e. my identity will not be revealed). 
 
 
 Yes 
No  
 
 
 
I understand that the researcher may post the questionnaires to me and may 
telephone me to collect my questionnaire answers. 
 
 Yes 
No  
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Appendix 7: Demographic Questionnaire 
 
Demographic Questionnaire for stroke survivor 
The following information will be used anonymously in the study. Please answer as many 
questions as possible. However, you do not have to answer anything you don’t want to.  
Thank you. 
 
Today’s Date: ______________________                 Participant #: [office use]____________ 
Age: ________                             Gender (please tick): 
              
Have you had more than 1 stroke? 
 
 
Date of first stroke:         /      / 
 
Date of most recent stroke (if applicable):  /      / 
 
Type of Stroke (if known):  
 
Location of the Stroke (if known): ___________________________ 
 
Age of leaving education: ______________________________ 
 
Highest qualifications obtained: __________________________ 
 
 
Are you in employment?   Are you retired?  
 
 
Current / previous work: 
___________________________________________________________________________
___________________________________________________________________________ 
 
Living 
circumstances: 
 
 
Have you been treated for any psychological condition (e.g. anxiety or depression) since 
your stroke?   
 
 
 
If yes, what was the condition and what treatment did you receive? 
___________________________________________________________________________
___________________________________________________________________________ 
 
Thank you 
 Male 
Female   Yes 
No  
 Yes 
No  
 Yes 
No  
 Living with a carer 
 Living with someone who is not a carer 
 Living alone 
 Yes 
No  
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Appendix 8: PHQ-9 
 
PHQ-9 
 
 
  Over the last 2 weeks, how often have you  
  been bothered by any of the following problems? 
    (Use “✔” to indicate your answer” 
 
 
 
Not at 
all 
 
 
 
Several 
days 
 
More 
than 
half the 
days 
 
 
Nearly       
every 
 day 
1.  Little interest or pleasure in doing things.......……… 0 1 2 3 
2.  Feeling down, depressed, or hopeless.………..…… 0 1 2 3 
3.  Trouble falling or staying asleep, or sleeping too 
much..................................................………..…….. 
 
  0 
 
1 
 
  2 
 
  3 
4.  Feeling tired or having little energy......……...……… 0 1 2 3 
5.  Poor appetite or overeating.......................……….…     0 1 2 3 
6.  Feeling bad about yourself — or that you are a failure   
or have let yourself or your family down………………….. 
 
  0 
 
1 
 
2 
 
  3 
7.  Trouble concentrating on things, such as reading the 
newspaper or watching television.……………………….. 
 
  0 
 
1 
 
2 
 
  3 
8.  Moving or speaking so slowly that other people could 
have noticed?  Or the opposite — being so fidgety or 
restless that you have been moving .around a lot more than 
usual..............……………………………………………….. 
 
 
 
 0 
 
 
 
1 
 
 
 
2 
 
 
 
 3 
9.  Thoughts that you would be better off dead or of hurting 
yourself in some way......…………………………………… 
 
 0 
 
1 
 
2 
 
 3 
 
                                                               Column totals          ___     +   ___  + ____  +   ___  
 
                                                                                                 
                                                                                                         =   Total Score _____   
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Appendix 9: GAD-7 
 
GAD-7 
 
  
    
 
 
    
=   Total Score _____   
 
 
 
 
 
 
 
 
 
 
  Over the last 2 weeks, how often have you   
  been bothered by the following problems? 
    (Use “✔” to indicate your answer” 
Not  
at all 
Several 
days 
More than 
half the 
days 
Nearly 
every day 
1.  Feeling nervous, anxious or on edge 0 1 2 3 
2.  Not being able to stop or control worrying 0 1 2 3 
3.  Worrying too much about different things 0 1 2 3 
4.  Trouble relaxing 0 1 2 3 
5.  Being so restless that it is hard to sit still 0 1 2 3 
6.  Becoming easily annoyed or irritable 0 1 2 3 
7.  Feeling afraid as if something awful  
     might happen 
0 1 2 3 
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Appendix 10: EQ-5D-5L 
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Appendix 11: Adult Hope Scale 
 
Read each item carefully.  Using the scale shown below, please select the number that 
best describes you and put that number in the blank provided. 
 
1=Definitely False       5=Slightly True 
2=Mostly False       6=Somewhat True 
3=Somewhat False       7=Mostly True 
4=Slightly False       8=Definitely True 
 
___ 1. I can think of many ways to get out of a jam. 
___ 2. I energetically pursue my goals. 
___ 3. I fell tired most of the time. 
___ 4. There are lots of ways around any problem. 
___ 5. I am easily downed in an argument. 
___ 6. I can think of many ways to get the things in life that are most important to me. 
___ 7. I worry about my health. 
___ 8. Even when others get discouraged, I know I can find a way to solve the problem. 
___ 9. My past experiences have prepared me well for my future. 
___ 10. I’ve been pretty successful in life. 
___ 11. I usually find myself worrying about something. 
___ 12. I meet the goals that I set for myself. 
 
Agency: ___________ 
 
Add Scores on items: 2, 9, 10 and 12.  Scores range from a 4 to a 32.  Higher scores 
reflect higher agency. 
 
Pathways: __________ 
 
Add scores on items: 1, 4, 6 and 8.  .  Scores range from a 4 to a 32.  Higher scores reflect 
higher pathways thinking. 
 
Total Hope Score:  ___________  (Add Score for Pathways to the Score for Agency) 
 
Add the agency and pathway scores.  Scores of 40 – 48 are hopeful, 48 – 56 moderately 
hopeful, and 56 or higher as high hope. 
 
Snyder, C.R., Harris, C., Anderson, J.R., Holleran, S.A., Irving, L.M., Sigmon, S.T., &… Harney, P. (1991). The 
will and the ways: Development and validation of an Individual-differences measure of hope. Journal 
of Personality and Social Psychology, 60, 570-585. 
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Appendix 12: Warwick and Edinburgh Mental Wellbeing Scale  
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Appendix 13 Debrief Form 
Debrief form 
I would like to thank you for taking part in this study! Your time and input is very much 
appreciated. 
The aim of this study was to evaluate the effectiveness of Acceptance and Commitment 
Therapy at reducing distress and improving well-being in stroke survivors and carers. We 
have used the questionnaire data that you have kindly completed, to achieve this.  The 
information you provided will help to plan care for stroke survivors and carers in the future. 
If you wish to have information about the results of the study please contact Sarah Harris 
(contact details overleaf) and she will send you a summary of the results as soon as they are 
available. 
Additionally, if you would like to make any comments please feel free to contact either 
myself or Professor Morris (contact details overleaf). 
Many thanks,     Supervised by, 
Sarah Harris      Dr Reg Morris 
Trainee Clinical Psychologist   Consultant Neuropsychologist 
 
If you would like more information about the project, please feel free to contact us: 
Researcher: 
Sarah Harris 
Trainee Clinical Psychologist, Postgraduate student. 
South Wales Doctoral Programme in Clinical Psychology 
11th Floor, School of Psychology, Tower Building, 
70 Park Place, 
Cardiff, 
CF10 3AT 
Email: sarah.harris7@wales.nhs.uk 
Tel: 029 20870582 
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Academic supervisor: 
Prof. Reg Morris  
Consultant Clinical Psychologist 
South Wales Doctoral Programme in Clinical Psychology 
Cardiff & Vale UHB 
Email: Reg.Morris@wales.nhs.uk 
Tel: 02920 206464 
 
If you have any concerns or complaints about the research you can contact the School of 
Psychology Research Ethics Committee in writing at: 
Secretary to the Research Ethics Committee 
School of Psychology, Tower Building 
70 Park Place, Cardiff, CF10 3AT 
Email: psychethics@cardiff.ac.uk 
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Appendix 14: NHS REC Ethical Approval Letter 
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Appendix 15: Sponsor Letter 
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Appendix 16: R&D Approval Letters Site 1 
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Appendix 17: R&D Approval Letters Site 2 
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Appendix 18: R&D Approval Letters Site 3 
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Appendix 19: R&D Approval Letters Site 4 
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Appendix 20: Email from Librarian 
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Appendix 21: PRISMA Checklist 
Section/topic  # Checklist item  
Reported 
on page #  
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.  10 
ABSTRACT   
Structured summary  2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, 
participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and 
implications of key findings; systematic review registration number.  
11 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.  13-16 
Objectives  4 Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, 
outcomes, and study design (PICOS).  
16 
METHODS   
Protocol and registration  5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide 
registration information including registration number.  
- 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, 
language, publication status) used as criteria for eligibility, giving rationale.  
17 
Information sources  7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify 
additional studies) in the search and date last searched.  
17 
Search  8 Present full electronic search strategy for at least one database, including any limits used, such that it could be 
repeated.  
17 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, 
included in the meta-analysis).  
17 
Data collection process  10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes 
for obtaining and confirming data from investigators.  
17 
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Section/topic  # Checklist item  
Reported 
on page #  
Risk of bias across studies  15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective 
reporting within studies).  
18 
Additional analyses  16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating 
which were pre-specified.  
- 
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at 
each stage, ideally with a flow diagram.  
19 & 39 
Study characteristics  18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and 
provide the citations.  
19 
Risk of bias within studies  19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12).  40 – 41  
Results of individual studies  20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each 
intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.  
22 – 26 
Synthesis of results  21 Present results of each meta-analysis done, including confidence intervals and measures of consistency.  - 
Risk of bias across studies  22 Present results of any assessment of risk of bias across studies (see Item 15).  20 
Additional analysis  23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 16]).  - 
DISCUSSION   
Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and 
simplifications made.  
- 
Risk of bias in individual 
studies  
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this was 
done at the study or outcome level), and how this information is to be used in any data synthesis.  
18 
Summary measures  13 State the principal summary measures (e.g., risk ratio, difference in means).  - 
Synthesis of results  14 Describe the methods of handling data and combining results of studies, if done, including measures of consistency 
(e.g., I
2
) for each meta-analysis.  
- 
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Summary of evidence  24 Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to 
key groups (e.g., healthcare providers, users, and policy makers).  
27-29 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of 
identified research, reporting bias).  
29 
Conclusions  26 Provide a general interpretation of the results in the context of other evidence, and implications for future research.  31 
FUNDING   
Funding  27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the 
systematic review.  
31 
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Appendix 23: CONSORT Checklist 
Section/Topic 
Item 
No Checklist item 
Reported 
on page No 
Title and abstract 
 1a Identification as a randomised trial in the title 42 
1b Structured summary of trial design, methods, results, and conclusions (for specific guidance see CONSORT for abstracts) 43 
Introduction 
Background and 
objectives 
2a Scientific background and explanation of rationale 45-49 
2b Specific objectives or hypotheses 49 
Methods 
Trial design 3a Description of trial design (such as parallel, factorial) including allocation ratio 49 
3b Important changes to methods after trial commencement (such as eligibility criteria), with reasons n/a 
Participants 4a Eligibility criteria for participants 49 
4b Settings and locations where the data were collected 49 
Interventions 5 The interventions for each group with sufficient details to allow replication, including how and when they were 
actually administered 
50-51 & 76 
Outcomes 6a Completely defined pre-specified primary and secondary outcome measures, including how and when they 
were assessed 
52-53 
6b Any changes to trial outcomes after the trial commenced, with reasons n/a 
Sample size 7a How sample size was determined 54 
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7b When applicable, explanation of any interim analyses and stopping guidelines n/a 
Randomisation:    
 Sequence 
generation 
8a Method used to generate the random allocation sequence 50 
8b Type of randomisation; details of any restriction (such as blocking and block size) 50 
 Allocation 
concealment 
mechanism 
9 Mechanism used to implement the random allocation sequence (such as sequentially numbered containers), 
describing any steps taken to conceal the sequence until interventions were assigned 
50 
 Implementation 10 Who generated the random allocation sequence, who enrolled participants, and who assigned participants to 
interventions 
50 
Blinding 11a If done, who was blinded after assignment to interventions (for example, participants, care providers, those 
assessing outcomes) and how 
50 
11b If relevant, description of the similarity of interventions - 
Statistical methods 12a Statistical methods used to compare groups for primary and secondary outcomes 54-55 
12b Methods for additional analyses, such as subgroup analyses and adjusted analyses n/a 
Results 
Participant flow (a 
diagram is strongly 
recommended) 
13a For each group, the numbers of participants who were randomly assigned, received intended treatment, and 
were analysed for the primary outcome 
55-56 & 77 
13b For each group, losses and exclusions after randomisation, together with reasons 56 & 77 
Recruitment 14a Dates defining the periods of recruitment and follow-up 55 
14b Why the trial ended or was stopped n/a 
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Baseline data 15 A table showing baseline demographic and clinical characteristics for each group 56 & 78 
Numbers analysed 16 For each group, number of participants (denominator) included in each analysis and whether the analysis was 
by original assigned groups 
56 
Outcomes and 
estimation 
17a For each primary and secondary outcome, results for each group, and the estimated effect size and its 
precision (such as 95% confidence interval) 
56-57&79-80 
17b For binary outcomes, presentation of both absolute and relative effect sizes is recommended n/a 
Ancillary analyses 18 Results of any other analyses performed, including subgroup analyses and adjusted analyses, distinguishing 
pre-specified from exploratory 
n/a 
Harms 19 All important harms or unintended effects in each group (for specific guidance see CONSORT for harms) n/a 
Discussion 
Limitations 20 Trial limitations, addressing sources of potential bias, imprecision, and, if relevant, multiplicity of analyses 62 
Generalisability 21 Generalisability (external validity, applicability) of the trial findings 62 
Interpretation 22 Interpretation consistent with results, balancing benefits and harms, and considering other relevant evidence 58-62 
Other information 
 
Registration 23 Registration number and name of trial registry - 
Protocol 24 Where the full trial protocol can be accessed, if available - 
Funding 25 Sources of funding and other support (such as supply of drugs), role of funders 64 
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